lutein has been researched along with Macular Degeneration in 297 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (1.35) | 18.2507 |
| 2000's | 110 (37.04) | 29.6817 |
| 2010's | 148 (49.83) | 24.3611 |
| 2020's | 35 (11.78) | 2.80 |
| Authors | Studies |
|---|---|
| Drakon, AK; Korchazhkina, NB; Kurguzova, AG; Sheludchenko, VM | 1 |
| Hackman, RM; Holt, RR; Keen, CL; Li, X; Morse, LS; Yiu, G | 1 |
| Li, SS; Wang, HH; Zhang, D | 1 |
| Kucharska, E; Majsterek, I; Mrowicka, M; Mrowicki, J | 1 |
| Arslangareeva, II; Bikbov, MM; Fakhretdinova, AA; Gilemzianova, LI; Gilmanshin, TR; Iakupova, EM; Jonas, JB; Kazakbaeva, GM; Khakimov, DA; Panda-Jonas, S; Tuliakova, AM; Zainullin, RM; Zinnatullin, AA | 1 |
| Cao, Y; Gkerdi, A; Li, Y; Reilly, J; Shu, X; Tan, Z | 1 |
| Bandello, F; Kumar, N; Kuppermann, BD; Parachuri, N; Sharma, A | 1 |
| Chen, F; Fan, Y; Jiang, H; Li, B; Li, C; Li, J; Li, Z; Liu, S; Ma, L; Ma, M; Mi, B; Pei, C; Shi, J; Wang, D; Wang, L | 1 |
| D'Aloisio, R; Delvecchio, G; Di Antonio, L; Di Iorio, A; Mastropasqua, R; Rispoli, M; Toto, L | 1 |
| Hackman, RM; Holt, RR; Keen, CL; Li, X; Morse, LS; Yiu, G; Zivkovic, AM | 1 |
| Csader, S; Kaarniranta, K; Korhonen, S; Schwab, U | 1 |
| Agrón, E; Chew, EY; Keenan, TDL | 1 |
| Honda, T; Inaba, M; Kikuya, T; Koike, C; Sakai, O; Sawabe, A; Takeda, R; Yoshida, K | 1 |
| Addo, EK; Bernstein, PS; Hartnett, ME | 1 |
| Dysli, C; Habra, O; Jaggi, D; Lincke, J; Solberg, Y; Wolf, S; Wyss, A; Zinkernagel, M | 1 |
| Arunkumar, R; Bernstein, PS | 1 |
| Dobrzynska, MM; Fiedorowicz, J | 1 |
| Evans, JR; Lawrenson, JG | 2 |
| Fan, W; Feng, L; Jiang, H; Nie, K | 1 |
| Arunkumar, R; Bernstein, PS; Gorusupudi, A | 1 |
| Kustra, R; Zanke, B | 1 |
| Agrón, E; Chew, EY; Chiu, CY; Clemons, TE; Fan, R; Klein, ML; Ratnapriya, R; Swaroop, A; van Asten, F | 2 |
| Ge, Y; Gou, J; He, H; Kong, J; Sun, R; Tang, X; Xu, J; Yin, T; Zhang, A; Zhang, Y | 1 |
| Kawasaki, R; Miura, S; Nishiyama, I; Sawa, M; Shigeta, R; Shunto, T; Yokoyama, A | 1 |
| SanGiovanni, JP; Subczynski, WK; Widomska, J | 1 |
| Chichger, H; Keegan, G; Pardhan, S | 1 |
| Fu, Z; Lam, WC; Lee, JC; Leung, HH; Li, LH; Lo, ACY | 1 |
| Suh, M; Walchuk, C | 1 |
| Kitaichi, N; Kosehira, M; Machida, N | 1 |
| Amonoo-Monney, S; Davey, PG; Evans, DW; Henderson, T; Lem, DW; Weis, R | 1 |
| Majeed, M; Majeed, S; Nagabhushanam, K | 1 |
| Huntjens, B; Perry, CB; Podella, C; Pratt, G; Pratt, SG; Richer, SP; Rutledge, GA | 1 |
| García-Montalvo, IA; Matías-Pérez, D | 1 |
| Abraldes, MJ; Caballero Arredondo, M; Calvo, P; Escobar-Barranco, JJ; Fernández-Robredo, P; García-Layana, A; Hernandez, M; Hernández-Galilea, E; Lopez-Sabater, MC; Mendez-Martínez, S; Nascimento, J; Olmedilla-Alonso, B; Pardiñas-Barón, N; Recalde, S; Silva, R; Zapata, MA | 1 |
| Jongjitphisut, N; Muangnoi, C; Paraoan, L; Phumsuay, R; Rashatasakhon, P; Rojsitthisak, P; Sangsawat, M; Waikasikorn, P | 1 |
| Aparicio, A; Bermejo López, LM; López-Sobaler, AM; Ortega Anta, RM; Rodríguez-Rodríguez, E | 1 |
| Azar, G; Masella, JJ; Mauget-Faÿsse, M; Quaranta-El Maftouhi, M | 1 |
| Ding, H; Jia, YP; Li, W; Liang, LP; Song, XB; Sun, L; Yu, HS; Zhang, LJ | 1 |
| Chong, YS; Leong, CO; Mai, CW; Wong, LC | 1 |
| Baldermann, S; Ebert, F; Frede, K; Kipp, AP; Schwerdtle, T | 1 |
| Bro, T; Karlsson, M | 1 |
| Hirano, E; Kobayashi, S; Kurihara, T; Minami, S; Nagai, N; Ozawa, Y; Shigeno, Y; Shinoda, H; Suzuki, M; Tsubota, K | 1 |
| Lindblad, AS | 1 |
| Nolan, JM; Phelan, D; Prado-Cabrero, A | 1 |
| Akuffo, KO; Beatty, S; Corcoran, L; Kelly, D; Leung, I; Nolan, JM; Peto, T; Stack, J; Stringham, J | 1 |
| Agrón, E; Chew, EY; Clemons, TE; Keenan, TD; Lu, Z; Ratnapriya, R; Simmons, M; Singhal, A; Swaroop, A; van Asten, F | 1 |
| Erdman, JW; Griffiths, JC; Jeon, S; Johnson, EJ; Mohn, ES; Ranard, KM | 1 |
| Agrón, E; Chew, EY; Clemons, TE; Papudesu, C | 1 |
| Akuffo, KO; Beatty, S; Feeney, J; Kenny, RA; Moran, R; Nolan, JM; O'Halloran, AM; Peto, T; Stack, J | 1 |
| Korobelnik, JF | 1 |
| Beatty, S; Nolan, J; Power, R | 1 |
| Agrón, E; Chew, EY; Clemons, TE; Danis, RG; Domalpally, A; Ferris, FL; Keenan, TD; Klein, ML; Ratnapriya, R; Rosenfeld, PJ; Sadda, S; Swaroop, A; van Asten, F; Wong, WT | 1 |
| Chae, SY; Park, G; Park, SY | 1 |
| Beirne, RO; McConnell, E | 1 |
| Alamán, AS; García-Layana, A; Recalde, S; Robredo, PF | 1 |
| Beatty, S; Biesalski, HK; Ellwood, K; Erdman, JW; Griffiths, JC; Hathcock, J; Johnson, E; Lauritzen, L; Marchioli, R; Rice, HB; Shao, A | 1 |
| Bartlett, H; Eperjesi, F; Howells, O | 1 |
| Arnold, C; Böhm, V; Dawczynski, J; Fröhlich, K; Jahreis, G; Jentsch, S; Winter, L | 1 |
| Abdel-Aal, el-SM; Akhtar, H; Ali, R; Zaheer, K | 1 |
| Cao, X; Chan, CC; Chew, EY; Ramkumar, HL; Shen, DF; Tuo, J; Zhang, J | 1 |
| Chalam, KV; Ferguson, LR; Koushan, K; Li, W; Rusovici, R | 1 |
| Beatty, S; Howard, A; Loskutova, E; Nolan, J | 1 |
| Ding, SH; Hang, L; Huang, BL; Li, W; Xu, XR; Zheng, SZ | 1 |
| Amouyel, P; Barberger-Gateau, P; Dartigues, JF; Delcourt, C; Delyfer, MN; Korobelnik, JF; Lambert, JC; Le Goff, M; Malet, F; Maubaret, C; Merle, BM; Rougier, MB | 1 |
| Attia, J; Buitendijk, GH; de Jong, PT; Flood, VM; Hofman, A; Holliday, EG; Iyengar, SK; Klaver, CC; Klein, BE; Klein, R; Lee, KE; Meuer, SM; Mitchell, P; Myers, C; Rochtchina, E; Smith, WT; Tan, AG; van Duijn, CM; Vingerling, JR; Wang, JJ | 1 |
| Grover, AK; Samson, SE | 1 |
| Dietzel, M; Hense, HW; Meyer zu Westrup, V; Pauleikhoff, D | 1 |
| Beatty, S; Meagher, KA; Nolan, JM | 1 |
| Arnold, C; Böhm, V; Jentsch, S; Schweitzer, D | 1 |
| Agrón, E; Bressler, SB; Chew, EY; Clemons, TE; Huynh, N; Nicholson, BP; Rosenfeld, PJ | 1 |
| Aronow, ME; Chew, EY | 1 |
| Akuffo, KO; Beatty, S; Dennison, J; Meagher, KA; Nolan, J; O'Regan, S; Peto, T; Stack, J | 1 |
| Eong, KG; Ho, H; Li, W; Neelam, K; Yip, CC | 1 |
| Ntzani, EE; Rizos, EC | 1 |
| Bertoni, AG; Bonds, DE; Chew, EY; Clemons, TE; Eaton, CB; Fine, LJ; Harrington, M; Hsia, J; Robinson, J; Worrall, BB | 1 |
| Kmietowicz, Z | 1 |
| Berendschot, TT; Haenen, GR; Kelly, ER; Kijlstra, A; Plat, J | 1 |
| Huang, FF; Lin, XM | 1 |
| Koo, E; Neuringer, M; SanGiovanni, JP | 1 |
| Akuffo, KO; Beatty, S; Connolly, E; Howard, A; Klein, BE; Klein, R; Loughman, J; Meuer, SM; Myers, CE; Nolan, JM; Sabour-Pickett, S; Stack, J | 1 |
| Berendschot, TT; Kelly, ER; Kijlstra, A; Lütjohann, D; Plat, J; van der Made, SM | 1 |
| Akuffo, KO; Beatty, S; Bolger, M; Dennison, J; Howard, AN; Loskutova, E; Moran, R; Mulcahy, R; Nolan, JM; Owens, N; Stack, J; Thurnham, DI | 1 |
| Berendschot, TT; Kijlstra, A; Makridaki, M; Murray, IJ; Tian, Y; van der Veen, RL | 1 |
| Dou, HL; Huang, FF; Huang, YM; Lin, XM; Lu, XR; Xu, XR; Zou, ZY | 1 |
| Beatty, S; Howard, AN; Nolan, JM; Thurnham, DI | 1 |
| Chen, X; Gong, Y; Jiang, C; Wang, X; Zhang, M; Zhang, Y | 1 |
| Ostrovskiĭ, MA; Panova, IG; Stroeva, OG | 1 |
| Greenberg, PB; Scott, IU; Yong, JJ | 1 |
| Li, Q; Liu, R; Ma, L; Qin, L; Wang, T; Wu, C; Zhang, B | 1 |
| Garhöfer, G; Schmetterer, L; Schmidl, D | 1 |
| Berendschot, TTJM; Kijlstra, A; Tian, Y; Webers, CAB | 1 |
| Acar, N; Baert, B; Bourdillon, A; Bretillon, L; Clerc, E; Depeint, F; Lecerf, JM; Mathiaud, A; Pouillart, P; Rodriguez, B; Schnebelen-Berthier, C; Thabuis, C | 1 |
| Hamułka, J; Nogal, D; Sulich, A | 1 |
| Dou, HL; Huang, FF; Huang, YM; Lin, XM; Xu, XR; Zou, ZY | 1 |
| Agrón, E; Chew, EY; Clemons, TE; Doss, LE; Ferris, FL; Glaser, TS; Nigam, D; Shih, G; Sperduto, RD | 1 |
| Akuffo, KO; Beatty, S; Howard, AN; Klein, BE; Klein, R; Meuer, SM; Moran, R; Nolan, JM; Sabour-Pickett, S; Stack, J; Thurnham, DI | 1 |
| Fischer, T | 2 |
| Gill, SS; Seitz, DP | 1 |
| Agrón, E; Bernstein, PS; Chew, EY; Clemons, TE; Grodstein, F; Launer, LJ | 1 |
| Blodi, BA; Gehrs, KM; Iyengar, SK; Johnson, E; Klein, ML; Liu, Z; Mares, JA; Meyers, KJ; Millen, AE; Robinson, J; Sarto, GE; Snodderly, DM; Tinker, L; Wallace, RB | 1 |
| Akuffo, KO; Beatty, S; Coen, RF; Dennison, J; Howard, AN; Kelly, D; Moran, R; Mulcahy, R; Nolan, JM; Stack, J | 1 |
| Bhatiwada, N; Ranganathan, A; Sheshappa, MB; Talahalli, RR; Vallikannan, B | 1 |
| Cho, E; Sastry, SM; Schaumberg, DA; Willett, WC; Wu, J | 1 |
| Bernstein, PS; Gellermann, W; Gohto, Y; Obana, A; Okazaki, S; Tanito, M | 1 |
| Wise, J | 1 |
| Bartlett, H; Eperjesi, F; Walsh, RP | 1 |
| Bernstein, PS; Gorusupudi, A; Henriksen, BS; Li, B; Nolan, JM; Shyam, R; Vachali, PP | 1 |
| Alam, M; Bartsch, DU; Camacho, N; Espina, M; Freeman, WR; Mendoza, N; You, QS | 1 |
| Cavarzeran, F; Masetto, M; Monterosso, G; Peto, T; Piermarocchi, R; Piermarocchi, S; Segato, T; Tognetto, D; Turrini, A | 1 |
| Agrón, E; Al-Holou, SN; Chew, EY; Clemons, TE; Ferris, FL; Sperduto, RD; Tucker, WR | 1 |
| Ebneter, A; Munk, MR; Wolf, S; Wolf-Schnurrbusch, UE; Zinkernagel, MS | 1 |
| Hammond, BR; Miller, LS; Renzi-Hammond, LM | 1 |
| Nelson, E; Salem, N; Yurko-Mauro, K | 1 |
| Bernstein, P; Chew, EY; Launer, L | 1 |
| Holzapfel, C | 1 |
| Komaroff, AL | 1 |
| Hammond, BR; Renzi-Hammond, LM | 1 |
| Du, JH; Liu, R; Liu, T; Liu, XH; Ma, L; Wu, SS | 1 |
| Scott, TM | 1 |
| Stringham, JM; Stringham, NT | 1 |
| Kamoshita, M; Kobayashi, S; Narimatsu, T; Osada, H; Ozawa, Y; Toda, E; Tsubota, K | 1 |
| Corvi, F; Falfoul, Y; Georges, A; Jung, C; Querques, G; Querques, L; Souied, EH | 1 |
| Bravo-Filho, V; Burnier, MN; Coblentz, J; Moreira-Neto, C; Vilà, N; Zoroquiain, P | 1 |
| Bernstein, PS; Gorusupudi, A; Nelson, K | 1 |
| Eisenhauer, B; Flood, VM; Liew, G; Natoli, S | 1 |
| Au Eong, KG; Goenadi, CJ; Lun, K; Neelam, K; Yip, CC | 1 |
| Akuffo, KO; Beatty, S; Feeney, J; Kenny, RA; Moran, R; Nolan, JM; O'Halloran, AM; Stack, J | 1 |
| Cho, E; Colditz, GA; Hankinson, SE; Rosner, B; Willett, WC | 1 |
| Austermann, U; Fobker, M; Heimes, B; Hense, HW; Pauleikhoff, D; Zeimer, M | 1 |
| Sweet, BV; Zhao, L | 1 |
| Hamułka, J; Nogal, D | 1 |
| Basu, A; Rhone, M | 1 |
| Hahn, A; Mang, B | 1 |
| Hawkins, WR | 1 |
| Szostak, WB; Szostak-Wegierek, D | 1 |
| Hammond, BR | 1 |
| Carpentier, S; Knaus, M; Suh, M | 1 |
| Chiu, CJ; Gensler, G; Klein, R; Milton, RC; Taylor, A | 1 |
| Beatty, S; Connolly, E; Loane, E; Loughman, J; Nolan, JM; O'Reilly, P; Stack, J | 1 |
| Coker, J; Larson, T | 1 |
| Benlian, P; Borel, P; Feingold, J; Kaplan, J; Leveziel, N; Munnich, A; Reynolds, R; Richard, F; Rozet, JM; Seddon, JM; Soubrane, G; Souied, EH; Zerbib, J | 1 |
| Bernstein, PS; Delori, FC; Richer, S; van Kuijk, FJ; Wenzel, AJ | 1 |
| Blodi, BA; Chappell, RJ; Mares, JA; Moeller, SM; Parekh, N; Ritenbaugh, C; Voland, RP; Wallace, RB | 1 |
| Berendschot, TT; Cruysberg, JR; Fuijkschot, J; Theelen, T; van der Veen, RL; Willemsen, MA | 1 |
| Chew, EY; Krishnadev, N; Meleth, AD | 1 |
| Algan, M; Cohen, SY; Conrath, J; Mauget-Faysse, M; Oubraham, H; Roquet, W | 1 |
| Beatty, S; Connolly, EE; Howard, AN; Loughman, J; Nolan, JM; Stack, J; Thurnham, DI | 1 |
| Beatty, S; Connolly, EE; Cronin, H; Kearney, P; Kenny, R; Loane, E; Loughman, J; Nolan, JM; O'Regan, C | 1 |
| Akkali, MC; Beatty, S; Connolly, EE; Kirby, ML; Loane, E; Nolan, JM; Stack, J | 1 |
| Athukorala, I; Basnayake, BM; Chandrika, UG; Colombagama, PW; Goonetilleke, A | 1 |
| Dawczynski, J; Lang, GE; Schweitzer, D | 1 |
| Johnson, EJ; Maras, JE; Rasmussen, HM; Tucker, KL | 1 |
| Chan, CW; Koo, SC; Wong, IY | 1 |
| Rothenbuehler, SP; Wolf, S; Wolf-Schnurrbusch, UE | 1 |
| Bieuvelet, S; Borel, P; de Edelenyi, FS; Drouault-Holowacz, S; Gorrand, JM; Lyan, B; Malezet-Desmoulin, C; Margotat, A; Meunier, N; Vincent-Baudry, S | 1 |
| Reynolds, R; Rosner, B; Seddon, JM | 1 |
| Blodi, BA; Chappell, RJ; Gehrs, KM; Johnson, E; Klein, ML; Larowe, T; Mares, JA; Millen, AE; Moeller, SM; Ritenbaugh, C; Sarto, GE; Snodderly, DM; Sondel, SA; Tinker, L; Voland, RP; Wallace, RB | 1 |
| Barker, FM; Gerss, J; Johnson, EJ; Koepcke, W; Neuringer, M; Schalch, W; Snodderly, DM | 1 |
| Claes, B; Dietzel, M; Heimes, B; Hense, HW; Pauleikhoff, D; Zeimer, M | 1 |
| Khoramnia, R; Wegner, A | 1 |
| Delyfer, MN; Korobelnik, JF; Rougier, MB | 1 |
| Dawczynski, J; Hammer, M; Jentsch, S; Schweitzer, D; Strobel, J | 1 |
| Bakri, SJ; Erie, JC; Olson, JH | 1 |
| Kalariya, NM; Ramana, KV; Vankuijk, FJ | 1 |
| Dharmarajan, TS; Norkus, EP; Norkus, KL; Schalch, W; Schierle, J | 1 |
| Beatty, S; Loane, E; McKay, GJ; Nolan, JM | 1 |
| Gomi, F; Nishida, K; Sasamoto, Y; Sawa, M; Tsujikawa, M | 1 |
| Głabska, D; Włodarek, D | 1 |
| Dragostinoff, N; Garhöfer, G; Kaya, S; Lasta, M; Pemp, B; Sacu, S; Schmetterer, L; Schmidt-Erfurth, U; Simader, C; Weigert, G; Werkmeister, RM | 1 |
| Dietzel, M; Heimes, B; Hense, HW; Pauleikhoff, D; Zeimer, M | 1 |
| Dou, HL; Huang, YB; Huang, YM; Lin, XM; Ma, L; Wu, YQ; Xu, XR; Zou, ZY | 1 |
| Coco, RM; Sanabria, MR | 1 |
| Beatty, S; Loughman, J; Nolan, JM; Sabour-Pickett, S | 1 |
| Bian, Q; Qin, T; Ren, Z; Shang, F; Wu, D | 1 |
| Chakravarthy, U; Graydon, R; Hogg, RE; Woodside, JV; Young, IS | 1 |
| Koto, T; Ozawa, Y; Sasaki, M; Shinoda, H; Tsubota, K; Uchida, A | 1 |
| Dragostinoff, N; Garhöfer, G; Kaya, S; Pemp, B; Sacu, S; Schmetterer, L; Schmidt-Erfurth, U; Weigert, G; Werkmeister, RM | 2 |
| Duda, M; Nawrocki, G; Subczynski, WK; Wisniewska-Becker, A | 1 |
| Berendschot, TT; Kelly, ER; Kijlstra, A; Tian, Y | 1 |
| Beatty, S; Gilbert, CE; Hammond, CJ; Liew, SH; Nolan, JM; Spector, TD; Van Kuijk, FJ | 1 |
| Bian, Q; Gao, S; Gierhart, D; Johnson, EJ; Qin, J; Shang, F; Sparrow, JR; Tang, G; Taylor, A; Zhou, J | 1 |
| Austermann, U; Dietzel, M; Heimes, B; Hense, HW; Pauleikhoff, D; Zeimer, M | 1 |
| Dong, PC; Dou, HL; Huang, YM; Lin, XM; Lu, XR; Ma, L; Pang, HL; Qian, F; Sun, TT; Wang, X; Xiao, X; Xu, XR; Zou, ZY | 1 |
| Chew, EY; Clemons, T; Danis, R; Domalpally, A; Ferris, FL; McBee, W; SanGiovanni, JP; Sperduto, R | 1 |
| Dong, PC; Dou, HL; Huang, YM; Lin, XM; Lu, XR; Ma, L; Pang, HL; Qian, F; Sun, TT; Wang, X; Xiao, X; Xu, XR; Yan, SF; Zou, ZY | 1 |
| Ahmed, F; Allman, S; Bernstein, PS; Ermakov, I; Gellermann, W; Liu, A; Sharifzadeh, M; Sheng, X | 1 |
| Beatty, S; Nolan, J | 1 |
| Neuringer, M; SanGiovanni, JP | 1 |
| Bartlett, HE; Berrow, EJ; Eperjesi, F; Gibson, JM | 1 |
| Beatty, S; Connolly, E; Cummins, W; Howard, AN; Meagher, KA; Nolan, JM; Thurnham, DI | 1 |
| Beatty, S; Chakravarthy, U; Denny, F; Muldrew, KA; Nolan, JM; Stevenson, MR; Woodside, JV | 1 |
| Dou, HL; Huang, YM; Lin, XM; Ma, L; Xu, XR; Yan, SF; Zou, ZY | 1 |
| Berendschot, TT; Carden, D; Makridaki, M; Murray, IJ; Parry, NR; van der Veen, RL | 1 |
| Cruysberg, JR; Hoyng, CB; Snellen, EL; Van Den Hoogen, GW; Verbeek, AL | 1 |
| Bonnefoy, M; Drai, J; Kostka, T | 1 |
| Bernstein, PS; Ermakov, IV; Gellermann, W; McClane, RW; Wintch, SW; Zhao, DY | 1 |
| Fadda, A; Falsini, B; Iarossi, G; Merendino, E; Piccardi, M; Valentini, P | 1 |
| Khachik, F | 1 |
| Bone, RA; Krinsky, NI; Landrum, JT | 1 |
| Bone, RA; Guerra, LH; Landrum, JT; Ruiz, CA | 1 |
| Borel, P; Cardinault, N; Gorrand, JM; Grolier, P; Rock, E; Tyssandier, V | 1 |
| Sies, H; Stahl, W | 1 |
| Gale, CR; Hall, NF; Martyn, CN; Phillips, DI | 1 |
| Bernstein, PS; Ermakov, IV; Gellermann, W; Wintch, SW; Zhao, DY | 1 |
| Bartlett, H; Eperjesi, F | 2 |
| Dagnelie, G; Semba, RD | 1 |
| Blanco, I; Granado, F; Olmedilla, B | 1 |
| Bird, AC; Fitzke, F; Lommatzsch, A; Pauleikhoff, D; Spital, G; Trieschmann, M; van Kuijk, E | 1 |
| Cohn, W; Hartmann, D; Manner, B; Schalch, W; Spitzer, V; Thürmann, PA | 1 |
| Alves-Rodrigues, A; Shao, A | 1 |
| Frankowski, J; Nyland, J; Pei, K; Pulido, J; Richer, S; Rudy, D; Statkute, L; Stiles, W; Tsipursky, M | 1 |
| Beatty, S; Carden, D; Feather, J; Koh, HH; Murray, IJ; Nolan, D | 1 |
| Li, J; Molldrem, KL; Simon, PW; Tanumihardjo, SA | 1 |
| Ciulla, TA; Hammond, BR | 1 |
| Desmettre, T; Lecerf, JM; Souied, EH | 1 |
| Blumberg, JB; Ribaya-Mercado, JD | 1 |
| Benzie, IF; Cheng, CY; Chung, WY; Szeto, YT | 1 |
| Johnson, EJ | 1 |
| Hammond, BR; Stringham, JM | 1 |
| Chakravarthy, U; Hogg, R | 1 |
| Cohen, MM | 1 |
| Behrens, T; Dasch, B; Fobker, M; Fuhs, A; Hense, HW; Meister, A; Pauleikhoff, D; Schmidt, J; Wellmann, J | 1 |
| Leung, IY; Max Snodderly, D; Neuringer, M; Sandstrom, MM; Zucker, CL | 1 |
| Abalain, JH; Cardinault, N; Carré, JL; Coudray, C; Grolier, P; Mazur, A; Rambeau, M; Rock, E; Sairafi, B | 1 |
| Jones, PJ; Santosa, S | 1 |
| Hodge, A; McCarty, CA; Robman, L; Taylor, HR; Vu, HT | 1 |
| Giligson, A | 1 |
| Heimes, B; Hense, HW; Pauleikhoff, D; Trieschmann, M | 1 |
| Barberger-Gateau, P; Carrière, I; Delage, M; Delcourt, C; Schalch, W | 1 |
| Flood, V; Mitchell, P; Rochtchina, E; Smith, W; Wang, JJ | 1 |
| Donaldson, MJ; Pulido, JS | 1 |
| Blodi, B; Mares, JA; Moeller, SM; Parekh, N; Ritenbaugh, C; Tinker, L; Wallace, RB | 1 |
| Hodge, A; McCarty, CA; Robman, L; Taylor, HR; Vu, H | 1 |
| Beatty, S; Loane, E; Nolan, JM; O' Donovan, O; Stack, J | 1 |
| Ellwood, KC; Trumbo, PR | 1 |
| Chappell, RJ; Gruber, MJ; Johnson, EJ; Klein, ML; LaRowe, TL; Mares, JA; Moeller, SM; Snodderly, DM; Wooten, BR | 1 |
| Berendschot, TT; Kanis, MJ; van Norren, D | 1 |
| Bone, RA; Chen, H; Chew, EY; de Monastario, F; de Monasterio, F; de Moura, FF; Ferris, FL; Khachik, F; Kim, J; Landrum, JT; Rosenthal, JM; Schleicher, RL; Thompson, DJ | 1 |
| Chew, EY; de Moura, FF; Douglass, LW; Ferris, FL; Khachik, F; Kim, J; Thompson, DJ | 1 |
| Au Eong, KG; Beatty, S; Neelam, K; Nolan, J; O'Connell, E | 1 |
| Biesalski, HK; Breithaupt, DE; Frank, J; Lambert, C; Lornejad-Schäfer, MR | 1 |
| Beatty, S; Nolan, JM; O'connell, E; Stack, J | 1 |
| Bartlett, HE; Eperjesi, F | 1 |
| Austermann, U; Beatty, S; Fobker, M; Heimes, B; Hense, HW; Nolan, JM; Pauleikhoff, D; Trieschmann, M | 1 |
| Cangemi, FE | 1 |
| Connor, SL; Connor, WE; Hughes, S; Johnson, EJ; Klein, ML; Wang, W | 1 |
| Alexander, R; Bird, AC; Hermans, P; Luthert, P; Pauleikhoff, D; Trieschmann, M; van Kuijk, FJ | 1 |
| Chew, E; Coleman, H | 1 |
| Anderson, RS; Chakravarthy, U; Hogg, RE; Zlatkova, MB | 1 |
| Devenport, J; Lang, JC; Richer, S | 1 |
| Coscas, G; Haddad, WM; Soubrane, G; Souied, E | 1 |
| Cohen, SY | 1 |
| Guggenbühl, N | 1 |
| Curran-Celentano, J; Fuld, K; Gerweck, C; Sheehan, JP; Stringham, JM; Wenzel, AJ | 1 |
| Beatty, S; Loane, E; Nolan, JM; Stack, J | 1 |
| Gallinaro, G; Parisi, V; Piermarocchi, S; Saviano, S; Tedeschi, M; Varano, M | 1 |
| Dimitrov, P; Guymer, R; Hodge, A; McCarty, C; Robman, L; Tikellis, G; Vu, H | 1 |
| Chew, EY; Clemons, TE; Ferris, FL; Gensler, G; Lindblad, AS; Milton, RC; SanGiovanni, JP; Seddon, JM; Sperduto, RD | 1 |
| Chappell, R; Klein, ML; LaRowe, TL; Mares, JA; Snodderly, DM; Wooten, BR | 1 |
| Jones, AA | 1 |
| Fric, E; Rehak, M; Wiedemann, P | 1 |
| Bernstein, PS; Fujii, H; Gohto, Y; Hiramitsu, T; Hirano, T; Hotta, Y; Iseki, K; Mizuno, S; Obana, A; Ohira, A; Tanito, M | 1 |
| Johnson, EJ; Renzi, LM | 1 |
| Beatty, S; Chakravarthy, U; van Kuijk, FJ | 1 |
| Lin, X; Wang, M | 1 |
| Leung, IY | 1 |
| Chew, EY; Coleman, HR; de Monasterio, F; Ferris, FL; Huang, LL; Kim, J; Schleicher, RL; Wong, WT | 1 |
| Caldarella, SM; Chung, HY; Johnson, EJ; Snodderly, DM | 1 |
| Bowen, P; Brady, WE; Klein, BE; Klein, R; Mares-Perlman, JA; Palta, M; Stacewicz-Sapuntzakis, M | 1 |
| Bone, RA; Kilburn, MD; Landrum, JT | 1 |
| Edwards, RB; Hammond, BR; Johnson, EJ; Krinsky, NI; Russell, RM; Snodderly, DM; Yeum, KJ | 1 |
| Bird, AC; Keunen, JE; Sommerburg, O; van Kuijk, FJ | 1 |
| Beuermann, B; Hammer, M; Lang, GE; Lang, GK; Remsch, H; Schweitzer, D; Spraul, CW; Thamm, E | 2 |
| Bone, RA; Chen, Y; Dixon, Z; Landrum, JT; Llerena, CM | 1 |
| Blumberg, JB; Jacques, PF; Moeller, SM | 1 |
| Bone, RA; Gomez, CM; Landrum, JT; Mayne, ST; Tibor, SE; Twaroska, EE | 1 |
| Beatty, S; Boulton, ME; Carden, D; Henson, DB; Koh, H; Murray, IJ | 1 |
| Block, G; Fisher, AI; Klein, R; Mares-Perlman, JA; Millen, AE; Palta, M; Wright, JD | 1 |
| Nilsson, SE; Sundelin, SP | 1 |
| Bird, AC; Pauleikhoff, D; van Kuijk, FJ | 1 |
| Jewell, VC; Northrop-Clewes, CA; Thurnham, DI; Tubman, R | 1 |
| Ciulla, TA; Cooper, DA; Curran-Celentano, J; Danis, RB; Hammond, BR; Pratt, LM | 1 |
| Ficek, TL; Hankinson, SE; Mares-Perlman, JA; Millen, AE | 1 |
| Krinsky, NI | 1 |
81 review(s) available for lutein and Macular Degeneration
| Article | Year |
|---|---|
Efficacy of different nutrients in age-related macular degeneration: A systematic review and network meta-analysis.
Topics: Antioxidants; beta Carotene; Carotenoids; Dietary Supplements; Humans; Lutein; Macular Degeneration; Network Meta-Analysis; Vitamin E; Vitamins; Zeaxanthins; Zinc | 2022 |
Lutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration-Neurodegenerative Disease.
Topics: Adult; Humans; Lutein; Macular Degeneration; Macular Pigment; Neurodegenerative Diseases; Zeaxanthins | 2022 |
Association of Nutrients, Specific Dietary Patterns, and Probiotics with Age-related Macular Degeneration.
Topics: Antioxidants; Carbohydrates; Carotenoids; Dietary Supplements; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Nutrients; Olive Oil; Probiotics; Quality of Life; Zeaxanthins; Zinc | 2022 |
Potential roles of dietary zeaxanthin and lutein in macular health and function.
Topics: Diet; Dietary Supplements; Female; Humans; Lutein; Macular Degeneration; Xanthophylls; Zeaxanthins | 2023 |
The Effect of Dietary Supplementations on Delaying the Progression of Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.
Topics: Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Visual Acuity; Xanthophylls; Zeaxanthins | 2022 |
Macular Pigment Carotenoids and Bisretinoid A2E.
Topics: Humans; Lutein; Macula Lutea; Macular Degeneration; Macular Pigment; Retina; Retinoids | 2023 |
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Topics: Antioxidants; beta Carotene; Dietary Supplements; Female; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Male; Malnutrition; Minerals; Vitamin A; Vitamin K; Vitamins; Zeaxanthins; Zinc | 2023 |
Effects of lutein supplementation in age-related macular degeneration.
Topics: Arabidopsis Proteins; Dietary Supplements; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Lutein; Macula Lutea; Macular Degeneration; Macular Pigment; Nuclear Proteins; Randomized Controlled Trials as Topic; Treatment Outcome; Visual Acuity | 2019 |
The macular carotenoids: A biochemical overview.
Topics: Carotenoids; Carrier Proteins; cis-trans-Isomerases; Glutathione S-Transferase pi; Humans; Lutein; Macula Lutea; Macular Degeneration; Macular Pigment; Membrane Proteins; Plant Leaves; Retina; Vegetables; Zeaxanthins | 2020 |
Why is Zeaxanthin the Most Concentrated Xanthophyll in the Central Fovea?
Topics: Eating; Fovea Centralis; Fruit; Humans; Lipid Bilayers; Lutein; Macular Degeneration; Nutritional Physiological Phenomena; Oxidation-Reduction; Oxidative Stress; Vegetables; Zeaxanthins | 2020 |
Lutein and zeaxanthin attenuates VEGF-induced neovascularisation in human retinal microvascular endothelial cells through a Nox4-dependent pathway.
Topics: Endothelial Cells; Humans; Lutein; Macular Degeneration; Microvessels; NADPH Oxidase 4; Reactive Oxygen Species; Retinal Vessels; Vascular Endothelial Growth Factor A; Zeaxanthins | 2020 |
Lutein Supplementation for Eye Diseases.
Topics: Animals; Biological Availability; Cataract; Diabetic Retinopathy; Diet; Dietary Supplements; Eye Diseases; Humans; Lutein; Macula Lutea; Macular Degeneration; Myopia; Plants, Edible; Retinopathy of Prematurity | 2020 |
Nutrition and the aging retina: A comprehensive review of the relationship between nutrients and their role in age-related macular degeneration and retina disease prevention.
Topics: Aging; Antioxidants; Choline; Diet; Dietary Supplements; Docosahexaenoic Acids; Fatty Acids, Unsaturated; Humans; Lutein; Macular Degeneration; Retina; Zeaxanthins | 2020 |
Fatty Acids and Lipid Derivatives Protecting Photooxidative Attack in Age-related Macular Degeneration.
Topics: Carotenoids; Dietary Supplements; Disease Progression; Fatty Acids; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Nutrition Therapy; Protective Agents; Sedentary Behavior; Smoking; Vitamins | 2021 |
The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases.
Topics: Age Factors; Animals; Cognition; Cognition Disorders; Dietary Supplements; Humans; Lutein; Macular Degeneration; Molecular Structure; Vision Disorders; Zeaxanthins | 2017 |
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Topics: Aged; Antioxidants; Dietary Supplements; Disease Progression; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Minerals; Quality of Life; Randomized Controlled Trials as Topic; Vitamin E; Vitamins; Zeaxanthins; Zinc | 2017 |
[Behind blue eyes – the evidence for ocular nutritional supplements on the Swedish market].
Topics: Antioxidants; Blueberry Plants; Dietary Supplements; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Evidence-Based Medicine; Humans; Lutein; Macular Degeneration; Sweden; Vision Disorders; Vitamins; Zeaxanthins | 2017 |
Dietary guidance for lutein: consideration for intake recommendations is scientifically supported.
Topics: Clinical Trials as Topic; Diet; Dietary Supplements; Fruit; Humans; Lutein; Macular Degeneration; Recommended Dietary Allowances; Vegetables | 2017 |
Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health.
Topics: Cataract; Diet; Eye; Functional Food; Humans; Lutein; Macular Degeneration; Nutritional Status; Nutritive Value; Xanthophylls; Zeaxanthins | 2013 |
The role of lutein in eye-related disease.
Topics: Aging; Animals; Cataract; Eye Diseases; Humans; Light; Lutein; Macular Degeneration; Oxidative Stress; Reactive Oxygen Species; Xanthophylls; Zeaxanthins | 2013 |
Antioxidants and vision health: facts and fiction.
Topics: Antioxidants; Blindness; Cataract; Dietary Supplements; Eye Diseases; Eye Infections; Glaucoma; Humans; Lutein; Macular Degeneration; Reactive Oxygen Species; Retinitis Pigmentosa; Vision, Ocular; Vitamins | 2014 |
Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.
Topics: Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Treatment Outcome; Visual Acuity; Xanthophylls; Zeaxanthins; Zinc Compounds | 2014 |
Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration.
Topics: Diet; Epigenesis, Genetic; Genetic Variation; Humans; Lipoproteins, HDL; Lutein; Macular Degeneration; Retina; Zeaxanthins | 2014 |
Role of lutein supplementation in the management of age-related macular degeneration: meta-analysis of randomized controlled trials.
Topics: Dietary Supplements; Humans; Lutein; Macular Degeneration; Macular Pigment; Randomized Controlled Trials as Topic; Visual Acuity | 2014 |
[Carotenoids of the human eye in prenatal and early postnatal development].
Topics: Carotenoids; Cell Differentiation; Diet; Eye; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Retina | 2013 |
Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration.
Topics: Dietary Supplements; Humans; Lutein; Macular Degeneration; Visual Acuity; Zeaxanthins | 2014 |
Nutritional supplements in age-related macular degeneration.
Topics: Administration, Oral; Antioxidants; Ascorbic Acid; beta Carotene; Copper; Dietary Supplements; Disease Progression; Drug Combinations; Humans; Lutein; Macular Degeneration; Vision Disorders; Vitamin E; Vitamins; Zeaxanthins; Zinc | 2015 |
Lutein and Factor D: two intriguing players in the field of age-related macular degeneration.
Topics: Animals; Complement Activation; Complement Factor D; Humans; Lutein; Macular Degeneration; Molecular Targeted Therapy | 2015 |
[Non-pharmacologic therapy of age-related macular degeneration, based on the etiopathogenesis of the disease].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Caloric Restriction; Carotenoids; Curcumin; Endothelium, Vascular; Fatty Acids, Omega-3; Feeding Behavior; Flavonoids; Glycemic Index; Humans; Inflammation; Lutein; Macular Degeneration; Motor Activity; Polyphenols; Risk Reduction Behavior; Smoking Cessation; Stress, Psychological; Weight Loss; Zeaxanthins | 2015 |
Variation in Carotenoid Content of Kale and Other Vegetables: A Review of Pre- and Post-harvest Effects.
Topics: Animals; Brassica; Humans; Lutein; Macular Degeneration; Plant Extracts; Vegetables; Zeaxanthins | 2015 |
Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease.
Topics: Animals; Antioxidants; Diet; Eye Diseases; Haplorhini; Humans; Lutein; Macula Lutea; Macular Degeneration; Retinal Pigments; Zeaxanthins | 2016 |
[Pharmacological therapy of age-related macular degeneration based on etiopathogenesis].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Aspirin; Bosentan; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infliximab; Lutein; Macular Degeneration; Melatonin; PPAR gamma; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes; Sulfonamides; Trimetazidine; Tumor Necrosis Factor-alpha; Ubiquinone; Vitamin D; Xanthophylls | 2015 |
Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
Topics: Aged; Aged, 80 and over; Diagnostic Techniques, Ophthalmological; Dietary Supplements; Dose-Response Relationship, Drug; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Macular Pigment; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Up-Regulation; Zeaxanthins | 2016 |
The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration.
Topics: Aging; Antioxidants; Diet; Dietary Supplements; Dose-Response Relationship, Drug; Humans; Incidence; Lutein; Macular Degeneration; Meta-Analysis as Topic; Micronutrients; Prevalence; Randomized Controlled Trials as Topic; Zeaxanthins | 2017 |
Lutein and Zeaxanthin-Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection.
Topics: Biological Availability; Diet; Dietary Supplements; Food Analysis; Humans; Lutein; Macular Degeneration; Zeaxanthins | 2017 |
Putative protective role of lutein and zeaxanthin in diabetic retinopathy.
Topics: Animals; Antioxidants; Diabetic Retinopathy; Dietary Supplements; Disease Models, Animal; Humans; Lutein; Macular Degeneration; Neuroprotective Agents; Reactive Oxygen Species; Zeaxanthins | 2017 |
Phytochemicals and age-related eye diseases.
Topics: Aged; Aging; Antioxidants; Cataract; Eye Diseases; Flavonoids; Glaucoma; Humans; Lutein; Macular Degeneration; Middle Aged; Nutritional Physiological Phenomena; Oxidative Stress; Phytotherapy; Plants, Edible; Xanthophylls; Zeaxanthins | 2008 |
[Lutein and eye health--current state of discussion].
Topics: Eye Diseases; Health; Humans; Lutein; Macular Degeneration | 2008 |
[Nutrition in prevention of age-related macular degeneration].
Topics: Aged; Aged, 80 and over; Antioxidants; Dietary Supplements; Humans; Lutein; Macular Degeneration; Middle Aged; Xanthophylls; Zeaxanthins | 2008 |
Possible role for dietary lutein and zeaxanthin in visual development.
Topics: Cataract; Humans; Lutein; Macular Degeneration; Vision, Ocular; Xanthophylls; Zeaxanthins | 2008 |
Associations between lutein, zeaxanthin, and age-related macular degeneration: an overview.
Topics: Adult; Aged; Aged, 80 and over; Aging; Animals; Antioxidants; Diet; Dietary Supplements; Female; Humans; Light; Lutein; Macular Degeneration; Male; Middle Aged; Retina; Risk Factors; Tissue Distribution; Xanthophylls; Zeaxanthins | 2009 |
The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders.
Topics: Carotenoids; Humans; Lutein; Macular Degeneration; Pigment Epithelium of Eye; Retinal Diseases; Risk Factors; Xanthophylls; Zeaxanthins | 2010 |
Nutritional supplements for age-related macular degeneration.
Topics: Antioxidants; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Nutritional Support; Vitamins; Xanthophylls; Zeaxanthins | 2010 |
Macular pigment and healthy vision.
Topics: Antioxidants; Cataract; Health Status; Humans; Lutein; Macula Lutea; Macular Degeneration; Retinal Pigments; Vision, Ocular; Xanthophylls; Zeaxanthins | 2009 |
Prevention of age-related macular degeneration.
Topics: Dietary Supplements; Fatty Acids, Omega-3; Humans; Lenses, Intraocular; Lutein; Macular Degeneration; Risk Reduction Behavior; Xanthophylls; Zeaxanthins | 2011 |
Nutritional supplementation and age-related macular degeneration.
Topics: Antioxidants; Dietary Supplements; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Nutritional Support; Vitamins; Xanthophylls; Zeaxanthins | 2011 |
Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis.
Topics: Age of Onset; Aged; Diet; Evidence-Based Medicine; Humans; Lutein; Macular Degeneration; Middle Aged; Risk; Wet Macular Degeneration; Xanthophylls; Zeaxanthins | 2012 |
A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration.
Topics: Carotenoids; Dietary Supplements; Humans; Lutein; Macula Lutea; Macular Degeneration; Oxidative Stress; Randomized Controlled Trials as Topic; Retina; Retinal Pigments; Xanthophylls; Zeaxanthins | 2012 |
Lutein: more than just a filter for blue light.
Topics: Animals; Biological Transport; Eye; Humans; Lutein; Macular Degeneration; Retinal Diseases; Scavenger Receptors, Class B | 2012 |
The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field.
Topics: Animals; Humans; Lutein; Macular Degeneration; Retina; Translational Research, Biomedical; Xanthophylls; Zeaxanthins | 2012 |
[Antioxidants to slow aging, facts and perspectives].
Topics: Aging; Alzheimer Disease; Animals; Antioxidants; Arteriosclerosis; Ascorbic Acid; Carotenoids; Cataract; Chronic Disease; Disease Models, Animal; Evidence-Based Medicine; Free Radicals; Humans; Lutein; Macular Degeneration; Neoplasms; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Vitamin E | 2002 |
Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye.
Topics: Age Factors; Aging; Antioxidants; beta Carotene; Cataract; Humans; Lutein; Macula Lutea; Macular Degeneration; Retina; Retinal Pigments; Risk Factors; Xanthophylls; Zeaxanthins | 2003 |
Non-nutritive bioactive constituents of plants: lycopene, lutein and zeaxanthin.
Topics: Aging; Antioxidants; beta Carotene; Carotenoids; Humans; Lutein; Lycopene; Macular Degeneration; Photochemistry; Plants, Edible; Skin Diseases; Sunscreening Agents; Xanthophylls; Zeaxanthins | 2003 |
Age-related macular degeneration and nutritional supplementation: a review of randomised controlled trials.
Topics: alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Dietary Supplements; Drug Combinations; Humans; Lutein; Macular Degeneration; Nylidrin; Randomized Controlled Trials as Topic; Vitamin E; Vitamins; Zinc | 2003 |
Nutritional and clinical relevance of lutein in human health.
Topics: beta Carotene; Biological Availability; Biomarkers; Cardiovascular Diseases; Cataract; Diet; Dietary Supplements; Fruit; Humans; Lutein; Macular Degeneration; Neoplasms; Nutritional Physiological Phenomena; Retina; Vegetables; Xanthophylls; Zeaxanthins | 2003 |
The science behind lutein.
Topics: Animals; Cardiovascular Physiological Phenomena; Cataract; Diet; Europe; Eye Diseases; Humans; Lutein; Macular Degeneration; Ocular Physiological Phenomena; Plant Physiological Phenomena; Skin Physiological Phenomena; United States | 2004 |
An ideal ocular nutritional supplement?
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Ginkgo biloba; Humans; Lutein; Macular Degeneration; Nutritional Physiological Phenomena; Riboflavin; Vitamin A; Vitamin B 12; Vitamin E; Xanthophylls; Zeaxanthins | 2004 |
[Nutrition and age-related macular degeneration].
Topics: Antioxidants; beta Carotene; Dietary Supplements; Humans; Longitudinal Studies; Lutein; Macular Degeneration; Micronutrients; Nutritional Physiological Phenomena; Oxidative Stress; Primary Prevention; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Xanthophylls; Zeaxanthins | 2004 |
Lutein and zeaxanthin and their potential roles in disease prevention.
Topics: Aging; Anticarcinogenic Agents; beta Carotene; Cataract; Coronary Disease; Humans; Lutein; Macular Degeneration; Neoplasms; Primary Prevention; Stroke; Xanthophylls; Zeaxanthins | 2004 |
Obesity, lutein metabolism, and age-related macular degeneration: a web of connections.
Topics: Age Factors; Humans; Lutein; Macular Degeneration; Obesity; Odds Ratio; Oxidative Stress; Risk Assessment; Risk Factors; United States; Xanthophylls; Zeaxanthins | 2005 |
Dietary lutein and zeaxanthin: possible effects on visual function.
Topics: Antioxidants; beta Carotene; Eye; Humans; Lutein; Macula Lutea; Macular Degeneration; Ocular Physiological Phenomena; Pigment Epithelium of Eye; Vision, Ocular; Xanthophylls; Zeaxanthins | 2005 |
AMD and micronutrient antioxidants.
Topics: Antioxidants; Clinical Trials as Topic; Diet; Humans; Lutein; Macular Degeneration; Micronutrients; Nutritional Physiological Phenomena; Oxidative Stress; Risk Factors | 2004 |
Treatment of nonexudative (dry) age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Exudates and Transudates; Humans; Laser Therapy; Lutein; Macular Degeneration; Plasmapheresis; Pregnadienediols; Retinal Drusen; Xanthophylls; Zeaxanthins | 2006 |
Risk factors for age-related maculopathy are associated with a relative lack of macular pigment.
Topics: Adult; Age Factors; Body Mass Index; Cholesterol; Diet; Feeding Behavior; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Photometry; Risk Factors; Sex Factors; Smoking; Xanthophylls; Zeaxanthins | 2007 |
Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims.
Topics: Aging; Cataract; Evidence-Based Medicine; Food Labeling; Food, Organic; Humans; Legislation, Food; Lutein; Macular Degeneration; Risk Factors; United States; United States Food and Drug Administration; Xanthophylls; Zeaxanthins | 2006 |
Macular carotenoids and age-related maculopathy.
Topics: Antioxidants; Humans; Lutein; Macula Lutea; Macular Degeneration; Oxidative Stress; Prognosis; Xanthophylls; Zeaxanthins | 2006 |
Nutritional supplementation in age-related macular degeneration.
Topics: Antioxidants; Dietary Fats, Unsaturated; Dietary Supplements; Humans; Lutein; Macular Degeneration; Nutritional Support; Xanthophylls; Zeaxanthins; Zinc | 2007 |
[Vitamins for prevention of age related macular degeneration: efficacy and risk].
Topics: Aged; beta Carotene; Causality; Comorbidity; Dietary Supplements; Humans; Lung Neoplasms; Lutein; Macular Degeneration; Middle Aged; Risk Assessment; Smoking; Vitamins; Xanthophylls; Zeaxanthins | 2006 |
[The source of antioxidants].
Topics: Aged; Antioxidants; beta Carotene; Dietary Supplements; Edible Grain; Food Analysis; Fruit; Humans; Lutein; Macular Degeneration; Middle Aged; Vegetables; Vitamins; Xanthophylls; Zeaxanthins | 2006 |
Age related macular degeneration--should your patients be taking additional supplements?
Topics: Age Factors; Antioxidants; Dietary Supplements; Disease Progression; Evidence-Based Medicine; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Risk Factors; Xanthophylls; Zeaxanthins | 2007 |
[Lutein and antioxidants in the prevention of age-related macular degeneration].
Topics: Antioxidants; Clinical Trials as Topic; Germany; Humans; Lutein; Macular Degeneration; Practice Patterns, Physicians'; Treatment Outcome | 2008 |
Lutein and age-related ocular disorders in the older adult: a review.
Topics: Aged; Aging; Antioxidants; Cataract; Humans; Lutein; Macular Degeneration; Risk Factors | 2007 |
Macular pigment and age-related macular degeneration: longitudinal data and better techniques of measurement are needed.
Topics: Diagnostic Techniques, Ophthalmological; Diet; Humans; Lutein; Macular Degeneration; Retinal Pigments; Xanthophylls; Zeaxanthins | 2008 |
[Protective role of lutein on light-damage of retina].
Topics: Animals; Antioxidants; Humans; Light; Lutein; Macula Lutea; Macular Degeneration; Protective Agents; Reactive Oxygen Species; Retina | 2008 |
Macular pigment: new clinical methods of detection and the role of carotenoids in age-related macular degeneration.
Topics: Diagnostic Techniques, Ophthalmological; Humans; Lutein; Macular Degeneration; Molecular Structure; Retina; Xanthophylls; Zeaxanthins | 2008 |
The potential role of dietary xanthophylls in cataract and age-related macular degeneration.
Topics: Age Factors; Antioxidants; beta Carotene; Cataract; Eggs; Humans; Lutein; Macular Degeneration; Retina; Risk Factors; Xanthophylls; Zeaxanthins | 2000 |
[Macular pigment and age-related macular degeneration].
Topics: Aged; beta Carotene; Humans; Lutein; Macular Degeneration; Oxidative Stress; Risk Factors; Sunlight; Xanthophylls; Zeaxanthins | 2001 |
Nutritional factors and visual function in premature infants.
Topics: Antioxidants; beta Carotene; Carotenoids; Humans; Infant, Newborn; Infant, Premature; Lutein; Macular Degeneration; Milk, Human; Oxidative Stress; Pigment Epithelium of Eye; Retina; Retinal Pigments; Vision Disorders; Weaning; Xanthophylls; Zeaxanthins | 2001 |
Ophthalmology. What you can do to protect your eyes.
Topics: Alcohol Drinking; Aspirin; Eye Injuries; Eye Protective Devices; Fibrinolytic Agents; Glaucoma; Humans; Hypertension; Lutein; Macular Degeneration | 2001 |
The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview.
Topics: Aging; beta Carotene; Cataract; Chronic Disease; Fruit; Heart Diseases; Humans; Lutein; Macular Degeneration; Neoplasms; Stroke; Tissue Distribution; Vegetables; Xanthophylls; Zeaxanthins | 2002 |
Possible biologic mechanisms for a protective role of xanthophylls.
Topics: Aging; Antioxidants; beta Carotene; Humans; Lutein; Macula Lutea; Macular Degeneration; Xanthophylls; Zeaxanthins | 2002 |
67 trial(s) available for lutein and Macular Degeneration
| Article | Year |
|---|---|
Goji Berry Intake Increases Macular Pigment Optical Density in Healthy Adults: A Randomized Pilot Trial.
Topics: Aged; Carotenoids; Dietary Supplements; Eating; Female; Healthy Volunteers; Humans; Lutein; Lycium; Macula Lutea; Macular Degeneration; Macular Pigment; Male; Middle Aged; Pilot Projects; Skin; Zeaxanthins | 2021 |
Effects of Astaxanthin, Lutein, and Zeaxanthin on Eye-Hand Coordination and Smooth-Pursuit Eye Movement after Visual Display Terminal Operation in Healthy Subjects: A Randomized, Double-Blind Placebo-Controlled Intergroup Trial.
Topics: Dietary Supplements; Double-Blind Method; Eye Movements; Healthy Volunteers; Humans; Lutein; Macular Degeneration; Macular Pigment; Visual Acuity; Zeaxanthins | 2023 |
The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study-a study protocol for a randomized controlled trial.
Topics: Carotenoids; Clinical Trials, Phase II as Topic; Dietary Supplements; Genetic Testing; Humans; Lutein; Macular Degeneration; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Rosaniline Dyes; Zeaxanthins | 2023 |
Effects of Lutein Supplementation in Japanese Patients with Unilateral Age-Related Macular Degeneration: The Sakai Lutein Study.
Topics: Age Factors; Aged; Diet; Dietary Supplements; Double-Blind Method; Female; Humans; Japan; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Prospective Studies; Vegetables | 2020 |
Clinical Effects of Dietary Supplementation of Lutein with High Bio-Accessibility on Macular Pigment Optical Density and Contrast Sensitivity: A Randomized Double-Blind Placebo-Controlled Parallel-Group Comparison Trial.
Topics: Adult; Aged; Biological Availability; Contrast Sensitivity; Dietary Supplements; Double-Blind Method; Female; Glare; Healthy Volunteers; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Visual Acuity; Young Adult | 2020 |
Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen-An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula.
Topics: Aged; Carotenoids; Dietary Supplements; Female; Humans; Lipids; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Retinal Drusen; Treatment Outcome; Visual Acuity; Zeaxanthins | 2020 |
An Open-Label Pilot Study on Macumax Supplementation for Dry-Type Age-Related Macular Degeneration.
Topics: Aged; Dietary Supplements; Humans; Lutein; Macular Degeneration; Middle Aged; Pilot Projects; Zeaxanthins | 2021 |
A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration.
Topics: Aged; Aged, 80 and over; Dietary Supplements; Docosahexaenoic Acids; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Nutrients; Phenylethyl Alcohol; Resveratrol; Treatment Outcome; Visual Acuity; Xanthophylls; Zeaxanthins | 2021 |
Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
Topics: Aged; Aged, 80 and over; Cataract Extraction; Dietary Supplements; Double-Blind Method; Female; Humans; Lens, Crystalline; Lutein; Macula Lutea; Macular Degeneration; Macular Pigment; Male; Optical Imaging; Visual Acuity; Zeaxanthins | 2017 |
The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial.
Topics: Aged; Antioxidants; Ascorbic Acid; Contrast Sensitivity; Double-Blind Method; Drug Therapy, Combination; Female; Glare; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Photometry; Reading; Trace Elements; Visual Acuity; Vitamin E; Zeaxanthins; Zinc | 2017 |
A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.
Topics: Aged; Cohort Studies; Complement Factor H; Double-Blind Method; Drug Combinations; Fatty Acids, Omega-3; Female; Follow-Up Studies; Genetic Association Studies; Genome-Wide Association Study; High-Temperature Requirement A Serine Peptidase 1; Humans; Lutein; Macular Degeneration; Male; Polymorphism, Single Nucleotide; Proteins; Retinal Drusen; Retinal Hemorrhage; Retinal Pigment Epithelium; Visual Acuity; Zeaxanthins | 2018 |
Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Cataract Extraction; Cause of Death; Cohort Studies; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Female; Follow-Up Studies; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Proportional Hazards Models; Slit Lamp Microscopy; Survival Rate; United States; Visual Acuity; Visually Impaired Persons; Zeaxanthins | 2018 |
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Topics: Aged; Aged, 80 and over; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Photography; Prospective Studies; Visual Acuity; Zeaxanthins | 2018 |
No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18
Topics: Aged; Aged, 80 and over; beta Carotene; Carotenoids; Complement Factor H; Dietary Supplements; Disease Progression; Double-Blind Method; Drug Combinations; Fatty Acids, Omega-3; Female; Genetic Association Studies; Genome-Wide Association Study; Genotyping Techniques; Humans; Lutein; Macular Degeneration; Male; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proteins; Visual Acuity; Zeaxanthins; Zinc Compounds | 2019 |
Effects of lutein and docosahexaenoic Acid supplementation on macular pigment optical density in a randomized controlled trial.
Topics: Aged; Dietary Supplements; Docosahexaenoic Acids; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Photometry; Placebos; Retinal Pigments; Visual Acuity | 2013 |
Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
Topics: Aged; Aged, 80 and over; Antioxidants; Capsules; Chromans; Chromatography, High Pressure Liquid; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Gas Chromatography-Mass Spectrometry; Humans; Lipids; Lutein; Macular Degeneration; Male; Middle Aged; Retinal Pigments; Visual Acuity; Xanthophylls; Zeaxanthins | 2013 |
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Topics: Aged; beta Carotene; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Double-Blind Method; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Incidence; Lung Neoplasms; Lutein; Macular Degeneration; Male; Middle Aged; Risk; Treatment Outcome; Vitamins; Xanthophylls; Zeaxanthins; Zinc | 2013 |
Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.
Topics: Aged; Aged, 80 and over; Cataract; Cohort Studies; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Lens Implantation, Intraocular; Lutein; Macular Degeneration; Male; Middle Aged; Phacoemulsification; Prospective Studies; Pseudophakia; Severity of Illness Index; Visual Acuity; Vitamins; Xanthophylls; Zeaxanthins | 2014 |
Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials.
Topics: Adult; Aged; Contrast Sensitivity; Dietary Supplements; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Glare; Healthy Volunteers; Humans; Lutein; Macular Degeneration; Male; Pharmaceutical Preparations; Photometry; Research Design; Retinal Pigments; Sickness Impact Profile; Surveys and Questionnaires; Tomography, Optical Coherence; Visual Acuity; Vitamins; Xanthophylls; Zeaxanthins | 2014 |
Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Risk; Treatment Outcome; Xanthophylls; Zeaxanthins | 2014 |
The effect of modified eggs and an egg-yolk based beverage on serum lutein and zeaxanthin concentrations and macular pigment optical density: results from a randomized trial.
Topics: Adult; Aged; Beverages; Diet; Dietary Supplements; Egg Yolk; Eggs; Female; Follow-Up Studies; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Retinal Pigments; Treatment Outcome; Zeaxanthins | 2014 |
Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration.
Topics: Administration, Oral; Aged; Contrast Sensitivity; Drug Therapy, Combination; Female; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Pharmaceutical Preparations; Photometry; Single-Blind Method; Visual Acuity; Zeaxanthins | 2014 |
Consuming a buttermilk drink containing lutein-enriched egg yolk daily for 1 year increased plasma lutein but did not affect serum lipid or lipoprotein concentrations in adults with early signs of age-related macular degeneration.
Topics: Aged; Beverages; Cardiovascular Diseases; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cultured Milk Products; Diet; Dietary Supplements; Disease Progression; Egg Yolk; Female; Humans; Intestinal Absorption; Lutein; Macular Degeneration; Male; Middle Aged; Phytosterols; Time Factors | 2014 |
Lutein supplementation leads to decreased soluble complement membrane attack complex sC5b-9 plasma levels.
Topics: Aged; Aged, 80 and over; Complement Activation; Complement Membrane Attack Complex; Dietary Supplements; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Lutein; Macular Degeneration; Male; Middle Aged | 2015 |
Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.
Topics: Aged; Dietary Supplements; Double-Blind Method; Drug Combinations; Electroretinography; Female; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Retina; Surveys and Questionnaires; Visual Field Tests; Visual Fields; Zeaxanthins | 2015 |
Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.
Topics: Aged; Chromatography, High Pressure Liquid; Densitometry; Diet; Double-Blind Method; Drug Compounding; Female; Healthy Volunteers; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Xanthophylls; Zeaxanthins | 2015 |
Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration.
Topics: Aged; Contrast Sensitivity; Female; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Quality of Life; Visual Acuity; Zeaxanthins | 2015 |
The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.
Topics: Aged; Aged, 80 and over; Cataract; Cataract Extraction; Cross-Sectional Studies; Diet; Diet Surveys; Female; Follow-Up Studies; Humans; Incidence; Lutein; Macular Degeneration; Male; Middle Aged; Odds Ratio; Prevalence; Prospective Studies; Risk Factors; Surveys and Questionnaires; United States; Vitamin B Complex; Zeaxanthins | 2015 |
Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration.
Topics: Administration, Oral; Carotenoids; Chromatography, High Pressure Liquid; Contrast Sensitivity; Dietary Supplements; Drug Compounding; Humans; Lutein; Macular Degeneration; Macular Pigment; Photometry; Single-Blind Method; Visual Acuity; Zeaxanthins | 2015 |
Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Algorithms; Ascorbic Acid; beta Carotene; Cognition; Copper; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Hispanic or Latino; Humans; Lost to Follow-Up; Lutein; Macular Degeneration; Male; Medication Adherence; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Racial Groups; Time Factors; Vitamins; Zeaxanthins; Zinc Oxide | 2015 |
Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids.
Topics: Adult; Aged; Carotenoids; Chromatography, High Pressure Liquid; Cognition Disorders; Double-Blind Method; Female; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Neuropsychological Tests; Photometry; Tomography, Optical Coherence; Zeaxanthins | 2015 |
Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements.
Topics: Adult; Contrast Sensitivity; Dietary Supplements; Female; Humans; Japan; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Prospective Studies; Visual Acuity; Zeaxanthins | 2015 |
The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cataract; Cataract Extraction; Disease Progression; Fatty Acids, Omega-3; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lutein; Macular Degeneration; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Prospective Studies; United States; Zeaxanthins | 2016 |
Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antioxidants; Contrast Sensitivity; Dietary Supplements; Double-Blind Method; Fatty Acids, Unsaturated; Female; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Prospective Studies; Visual Acuity; Zeaxanthins | 2015 |
Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
Topics: Adolescent; Adult; Biomarkers; Chromatography, High Pressure Liquid; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Healthy Volunteers; Humans; Lutein; Macula Lutea; Macular Degeneration; Macular Pigment; Male; Photometry; Time Factors; Visual Acuity; Young Adult; Zeaxanthins | 2016 |
[The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antioxidants; Dietary Supplements; Female; Humans; Lutein; Macular Degeneration; Male; Metabolic Clearance Rate; Middle Aged; Retinal Pigments; Xanthophylls; Zeaxanthins | 2009 |
Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.
Topics: Acrylic Resins; Aged; Double-Blind Method; Feeding Behavior; Female; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Lutein; Macular Degeneration; Male; Optics and Photonics; Oxidative Stress; Phacoemulsification; Photometry; Prospective Studies; Radiation Injuries; Retina; Retinal Pigments; Visual Acuity; Xanthophylls; Zeaxanthins | 2009 |
[Objective measurement of macular optical density].
Topics: Aged; Aged, 80 and over; Densitometry; Diagnostic Techniques, Ophthalmological; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Reproducibility of Results; Retinal Pigments; Sensitivity and Specificity; Treatment Outcome | 2011 |
Macular pigment density at the site of altered fundus autofluorescence.
Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Lasers; Lutein; Macular Degeneration; Male; Middle Aged; Ophthalmoscopy; Prospective Studies; Retinal Pigments; Xanthophylls; Zeaxanthins | 2011 |
Serum lutein response is greater from free lutein than from esterified lutein during 4 weeks of supplementation in healthy adults.
Topics: Adult; Antioxidants; Biological Availability; Cholesterol; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Esterification; Female; Humans; Linear Models; Lutein; Macular Degeneration; Male; Middle Aged; Young Adult | 2010 |
Effect of 1-year lutein supplementation on macular pigment optical density and visual function.
Topics: Aged; Antioxidants; Central Serous Chorioretinopathy; Contrast Sensitivity; Dietary Supplements; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Prospective Studies; Retinal Pigments; Spectrometry, Fluorescence; Time Factors; Visual Acuity | 2011 |
Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration.
Topics: Aged; Blood Pressure; Dietary Supplements; Double-Blind Method; Female; Heart Rate; Humans; Intraocular Pressure; Lutein; Macular Degeneration; Male; Retina; Retinal Pigments; Tomography, Optical Coherence; Visual Acuity; Visual Field Tests | 2011 |
The effect of lutein- and zeaxanthin-rich foods v. supplements on macular pigment level and serological markers of endothelial activation, inflammation and oxidation: pilot studies in healthy volunteers.
Topics: Adult; Antioxidants; Biomarkers; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Female; Functional Food; Humans; Intention to Treat Analysis; Lutein; Macular Degeneration; Male; Middle Aged; Northern Ireland; Oxidative Stress; Pilot Projects; Retina; Retinal Pigments; Risk; Xanthophylls; Young Adult; Zeaxanthins | 2012 |
Short- and mid-term repeatability of macular pigment optical density measurements using spectral fundus reflectance.
Topics: Adult; Aged; Aged, 80 and over; Densitometry; Diagnostic Techniques, Ophthalmological; Double-Blind Method; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Reference Values; Reproducibility of Results; Retinal Pigments; Xanthophylls; Young Adult; Zeaxanthins | 2012 |
Profiles of macular pigment optical density and their changes following supplemental lutein and zeaxanthin: new results from the LUNA study.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Dietary Supplements; Drug Combinations; Female; Follow-Up Studies; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Radiography; Retina; Retinal Pigments; Xanthophylls; Zeaxanthins | 2012 |
Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.
Topics: Aged; Densitometry; Dietary Supplements; Double-Blind Method; Electroretinography; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Retina; Treatment Outcome; Visual Acuity; Xanthophylls; Zeaxanthins | 2012 |
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
Topics: Aged; Aged, 80 and over; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Epidemiologic Methods; Fatty Acids, Omega-3; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Research Design; Treatment Outcome; Visual Acuity; Xanthophylls; Zeaxanthins | 2012 |
Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Topics: Aged; Contrast Sensitivity; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Feeding Behavior; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Photic Stimulation; Prospective Studies; Retina; Retinal Pigments; Rhodopsin; Surveys and Questionnaires; Visual Acuity; Xanthophylls; Zeaxanthins | 2012 |
Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center.
Topics: Aged; Aged, 80 and over; Biomarkers; Carotenoids; Dietary Supplements; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Retinal Pigments; Skin; Xanthophylls; Zeaxanthins | 2012 |
The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy -- a randomised controlled trial.
Topics: Aged; Aged, 80 and over; Antioxidants; Dietary Supplements; Electroretinography; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Retina; Visual Acuity | 2013 |
Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration.
Topics: Aged; Biological Availability; Dietary Supplements; Double-Blind Method; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Reference Values; Retina; Xanthophylls; Zeaxanthins | 2013 |
Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; Contrast Sensitivity; Double-Blind Method; Drug Therapy, Combination; Female; Fluorometry; Humans; Lutein; Macular Degeneration; Male; Mass Spectrometry; Middle Aged; Spectrum Analysis, Raman; Tablets; Trace Elements; Treatment Outcome; Visual Acuity; Vitamin E; Xanthophylls; Zeaxanthins | 2013 |
Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration.
Topics: Aged; Asian People; Chromatography, High Pressure Liquid; Dietary Supplements; Double-Blind Method; Female; Humans; Linear Models; Lutein; Macular Degeneration; Male; Middle Aged; Xanthophylls; Zeaxanthins | 2013 |
Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study.
Topics: Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Dietary Supplements; Double-Blind Method; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Photography; Retinal Pigments; Visual Acuity | 2013 |
Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment.
Topics: Aged; Aged, 80 and over; Antioxidants; Dietary Supplements; Electroretinography; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Niacinamide; Pilot Projects; Retina; Vitamin E | 2003 |
Plasma kinetics of zeaxanthin and 3'-dehydro-lutein after multiple oral doses of synthetic zeaxanthin.
Topics: Administration, Oral; Adult; beta Carotene; Biological Availability; Dietary Supplements; Dose-Response Relationship, Drug; Female; Humans; Lutein; Macular Degeneration; Male; Risk Factors; Xanthophylls; Zeaxanthins | 2004 |
Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).
Topics: Aged; Antioxidants; Case-Control Studies; Contrast Sensitivity; Dietary Supplements; Disease Progression; Double-Blind Method; Female; Glare; Humans; Lutein; Macular Degeneration; Male; Minerals; Treatment Outcome; Visual Acuity; Vitamins | 2004 |
Lutein and beta-carotene from lutein-containing yellow carrots are bioavailable in humans.
Topics: Adult; Area Under Curve; beta Carotene; Biological Availability; Cross-Over Studies; Daucus carota; Dietary Supplements; Double-Blind Method; Female; Humans; Intestinal Absorption; Lutein; Macular Degeneration; Male; Metabolic Clearance Rate; Plants, Genetically Modified | 2004 |
Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial.
Topics: Adolescent; Adult; beta Carotene; Dietary Supplements; Drugs, Chinese Herbal; Fasting; Humans; Lutein; Lycium; Macular Degeneration; Middle Aged; Nutritive Value; Phytotherapy; Single-Blind Method; Xanthophylls; Zeaxanthins | 2005 |
Dose-ranging study of lutein supplementation in persons aged 60 years or older.
Topics: Administration, Oral; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Dietary Supplements; Dose-Response Relationship, Drug; Feeding Behavior; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Pilot Projects; Visual Acuity; Visual Fields; Xanthophylls; Zeaxanthins | 2006 |
The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Carotenoids; Chromatography, High Pressure Liquid; Diet; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Vitamin A; Xanthophylls; Zeaxanthins | 2006 |
Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antioxidants; Contrast Sensitivity; Dietary Supplements; Double-Blind Method; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Minerals; Prospective Studies; Treatment Outcome; Vitamins | 2007 |
TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antioxidants; Case-Control Studies; Contrast Sensitivity; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Prospective Studies; Taurine; Treatment Outcome; Visual Acuity; Zinc | 2007 |
LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
Topics: Aged; Antioxidants; Atrophy; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Retinal Pigments; Time Factors; Xanthophylls | 2007 |
Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.
Topics: Administration, Oral; Aged; Antioxidants; Ascorbic Acid; Carotenoids; Copper; Electroretinography; Female; Follow-Up Studies; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Retina; Visual Acuity; Visual Fields; Vitamin E; Xanthophylls; Zeaxanthins; Zinc | 2008 |
Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Diet; Dietary Fats; Disease Progression; Female; Follow-Up Studies; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Odds Ratio; Retrospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome; Xanthophylls; Zeaxanthins | 2007 |
The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Dietary Supplements; Docosahexaenoic Acids; Female; Humans; Lipoproteins; Lutein; Macula Lutea; Macular Degeneration; Middle Aged; Retina | 2008 |
149 other study(ies) available for lutein and Macular Degeneration
| Article | Year |
|---|---|
[Pharmacological and physiotherapeutic methods of treating non-exudative age-related macular degeneration].
Topics: Disease Progression; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Retinal Drusen; Zeaxanthins | 2021 |
Macular pigment optical density and its determinants in a Russian population: the ural eye and medical study.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Lutein; Macular Degeneration; Macular Pigment; Middle Aged; Pseudophakia; Zeaxanthins | 2022 |
Supplemental nutrition for retinal health: Evidence based analysis of commercial preparations in India.
Topics: Antioxidants; Dietary Supplements; Humans; Lutein; Macular Degeneration; Retina | 2022 |
Dietary vitamins, carotenoids and their sources in relation to age-related macular degeneration risk in China: a population-based case-control study.
Topics: Carotenoids; Case-Control Studies; Humans; Lutein; Macular Degeneration; Vitamin A; Vitamin K; Vitamins; Zeaxanthins | 2023 |
Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants.
Topics: Antioxidants; Bromelains; Cholecalciferol; Choroid; Dietary Supplements; Folic Acid; Humans; Lutein; Macular Degeneration; Retrospective Studies; Tomography, Optical Coherence; Xanthophylls | 2022 |
Dietary nutrient intake and cognitive function in the Age-Related Eye Disease Studies 1 and 2.
Topics: Cognition; Dietary Supplements; Eating; Humans; Lutein; Macular Degeneration; Vitamins; Zeaxanthins | 2023 |
Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) - A pilot study.
Topics: Cohort Studies; Dietary Supplements; Humans; Lutein; Macular Degeneration; Macular Pigment; Ophthalmoscopy; Pilot Projects; Prospective Studies; Zeaxanthins | 2023 |
Lutein and zeaxanthin - radio- and chemoprotective properties. Mechanism and possible use.
Topics: Animals; Diet; Humans; Lutein; Macular Degeneration; Mice; Neoplasms; Xanthophylls; Zeaxanthins | 2023 |
Re: Van Asten et al.: No CFH/ARMS2 interaction with omega-3 fatty acids, low vs high zinc, or β-carotene versus Lutein and Zeaxanthin on progression of age-related macular degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study
Topics: beta Carotene; Dietary Supplements; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Proteins; Zeaxanthins; Zinc | 2020 |
Reply.
Topics: beta Carotene; Eye Diseases; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Zeaxanthins; Zinc | 2020 |
Penetratin-modified lutein nanoemulsion
Topics: Animals; Apoptosis; Cell Line; Cell-Penetrating Peptides; Electroretinography; Emulsions; Eye; Gels; Humans; Iodates; Lutein; Macular Degeneration; Male; Nanoparticles; Rabbits; Rats, Sprague-Dawley; Reactive Oxygen Species | 2020 |
Foveal macular pigment dip in offspring of age-related macular degeneration patients is inversely associated with omega-3 index.
Topics: Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Female; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Zeaxanthins | 2020 |
Protective Effects of a Lutein Ester Prodrug, Lutein Diglutaric Acid, against H
Topics: Antioxidants; Apoptosis Regulatory Proteins; Catalase; Cell Line; Cytochromes c; Drug Evaluation, Preclinical; Epithelial Cells; Gene Expression Regulation; Glutathione; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Lutein; Macular Degeneration; MAP Kinase Signaling System; Molecular Structure; Oxidative Stress; Prodrugs; Reactive Oxygen Species; Retinal Pigment Epithelium | 2021 |
[Involvement of egg antioxidant components in macular protection and vision improvement].
Topics: Antioxidants; Eggs; Humans; Lutein; Macular Degeneration; Visual Acuity; Zeaxanthins | 2021 |
Lutein improves cell viability and reduces Alu RNA accumulation in hydrogen peroxide challenged retinal pigment epithelial cells.
Topics: Alu Elements; Cell Line; Cell Survival; DEAD-box RNA Helicases; Drug Therapy, Combination; Epithelial Cells; Humans; Hydrogen Peroxide; Lutein; Macular Degeneration; Retinal Pigment Epithelium; Ribonuclease III; RNA; Zeaxanthins | 2018 |
Lutein Activates the Transcription Factor Nrf2 in Human Retinal Pigment Epithelial Cells.
Topics: Cell Line; Epithelial Cells; Heme Oxygenase-1; Humans; Lutein; Macular Degeneration; NF-E2-Related Factor 2; Retinal Pigment Epithelium | 2017 |
Absolute and estimated values of macular pigment optical density in young and aged Asian participants with or without age-related macular degeneration.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Retina; Young Adult; Zeaxanthins | 2017 |
The Role of Macular Pigment Density Measures in Future Clinical Studies of Age-Related Macular Degeneration.
Topics: Dietary Supplements; Humans; Lutein; Macular Degeneration; Macular Pigment; Zeaxanthins | 2017 |
Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations.
Topics: Dietary Supplements; Drug Stability; Drug Storage; Humans; Lutein; Macular Degeneration; Zeaxanthins | 2017 |
The Relationship Between Plasma Concentrations of Lutein and Zeaxanthin with Self-Reported and Actual Prevalence of AMD in an Irish Population-Based Sample.
Topics: Aged; Female; Follow-Up Studies; Humans; Ireland; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Population Surveillance; Prevalence; Prospective Studies; Self Report; Zeaxanthins | 2018 |
Questioning Macular Pigment Measurement Methods and Genetic Risk of Age-Related Macular Degeneration-Reply.
Topics: Dietary Supplements; Humans; Lutein; Macular Degeneration; Macular Pigment; Zeaxanthins | 2018 |
Questioning Macular Pigment Measurement Methods and Genetic Risk of Age-Related Macular Degeneration.
Topics: Dietary Supplements; Humans; Lutein; Macular Degeneration; Macular Pigment; Zeaxanthins | 2018 |
Lutein protects human retinal pigment epithelial cells from oxidative stress‑induced cellular senescence.
Topics: Antioxidants; Cell Line; Cell Survival; Cellular Senescence; Epithelial Cells; Humans; Lutein; Macular Degeneration; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Retinal Pigment Epithelium | 2018 |
Investigation of the relationship between macular pigment levels and rod-mediated dark adaptation in intermediate age-related macular degeneration.
Topics: Aged; Case-Control Studies; Cross-Sectional Studies; Dark Adaptation; Diagnostic Techniques, Ophthalmological; Female; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Visual Acuity; Zeaxanthins | 2019 |
Nutrient reference values for bioactives: new approaches needed? A conference report.
Topics: Brain; Carotenoids; Child; Diet; Fatty Acids, Omega-3; Food; Food Labeling; Health Promotion; Humans; Lutein; Macular Degeneration; Nutrition Policy; Nutritional Requirements; Reference Values; United States; Vision, Ocular; Xanthophylls; Zeaxanthins | 2013 |
Macular pigment optical density in young adults of South Asian origin.
Topics: Adolescent; Adult; Asian People; Densitometry; Environment; Feeding Behavior; Female; Humans; Life Style; Lutein; Macula Lutea; Macular Degeneration; Male; Photometry; Retinal Pigments; Surveys and Questionnaires; White People; Xanthophylls; Young Adult; Zeaxanthins | 2013 |
Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Chemokine CCL2; CX3C Chemokine Receptor 1; Cyclooxygenase 2; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Gene Expression Profiling; Interleukin-1beta; Lutein; Macular Degeneration; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; Nitric Oxide Synthase Type II; Phenotype; Pyridinium Compounds; Receptors, Chemokine; Retina; Retinal Degeneration; Retinoids; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Xanthophylls; Zeaxanthins | 2013 |
Macular pigment and its contribution to vision.
Topics: Diet; Dietary Supplements; Glare; Humans; Lutein; Macula Lutea; Macular Degeneration; Neurophysiology; Vision, Ocular; Xanthophylls; Zeaxanthins | 2013 |
[Prevention and treatment of age-related macular degeneration by extract of Fructus lycii and its constituents lutein/zeaxanthin: an in vive and in vitro experimental research].
Topics: Animals; Cathepsin B; Cystatin C; Drugs, Chinese Herbal; Female; Hydrogen Peroxide; Lutein; Macular Degeneration; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Pigment Epithelium of Eye; Tissue Inhibitor of Metalloproteinase-2; Xanthophylls; Zeaxanthins | 2013 |
Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study.
Topics: Age Factors; Aged; Aged, 80 and over; Female; Genotype; Humans; Lipase; Lipoprotein Lipase; Lipoproteins, HDL; Lutein; Macular Degeneration; Male; Polymorphism, Single Nucleotide; Prospective Studies; Xanthophylls; Zeaxanthins | 2013 |
Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations.
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Complement Factor H; Diet; Fatty Acids, Omega-3; Feeding Behavior; Female; Fish Products; Fruit; Genetic Predisposition to Disease; Genotyping Techniques; Humans; Incidence; Lutein; Macular Degeneration; Male; Middle Aged; Molecular Epidemiology; Netherlands; New South Wales; Proteins; Surveys and Questionnaires; Vegetables; Xanthophylls; Zeaxanthins; Zinc Compounds | 2014 |
The association of retinal structure and macular pigment distribution.
Topics: Aged; Complement Factor H; Female; Follow-Up Studies; Humans; Lutein; Macular Degeneration; Male; Polymorphism, Single Nucleotide; Prospective Studies; Proteins; Retina; Retinal Pigments; Tomography, Optical Coherence; Xanthophylls; Zeaxanthins | 2014 |
Regarding macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration.
Topics: Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Xanthophylls | 2014 |
Regarding macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration--reply.
Topics: Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Xanthophylls | 2014 |
The spatial profile of macular pigment in subjects from a Singapore Chinese population.
Topics: Adult; Aged; Cell Count; Cross-Sectional Studies; Female; Humans; Incidence; Lutein; Macula Lutea; Macular Degeneration; Male; Microscopy, Acoustic; Middle Aged; Photic Stimulation; Population Surveillance; Prevalence; Prognosis; Reference Values; Retinal Pigment Epithelium; Retinal Pigments; Risk Factors; Singapore; Xanthophylls; Young Adult; Zeaxanthins | 2014 |
ω-3 Fatty acids and lutein + zeaxanthin supplementation for the prevention of cardiovascular disease.
Topics: Cardiovascular Diseases; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Lutein; Macular Degeneration; Male; Xanthophylls; Zeaxanthins | 2014 |
Omega 3 supplements do not reduce cardiovascular risk in elderly.
Topics: Cardiovascular Diseases; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Lutein; Macular Degeneration; Male; Xanthophylls | 2014 |
[Comparison of daily intake of lutein+zeaxanthin, serum concentration of lutein/zeaxanthin and lipids profile between age-related macular degeneration patients and controls].
Topics: Case-Control Studies; Humans; Lipids; Lutein; Macular Degeneration; Zeaxanthins | 2014 |
Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: an exploratory study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Diet; Female; Humans; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Neuropsychological Tests; Retina; Visual Acuity; Zeaxanthins | 2014 |
Ocular nutritional supplements: are their ingredients and manufacturers' claims evidence-based?
Topics: Ascorbic Acid; beta Carotene; Chemistry, Pharmaceutical; Dietary Supplements; Drug Compounding; Drug Industry; Evidence-Based Practice; Humans; Lutein; Macular Degeneration; Niacin; Riboflavin; Vitamin E | 2015 |
Incorporation of lutein and docosahexaenoic acid from dietary microalgae into the retina in quail.
Topics: Animals; Biological Availability; Diet; Dietary Supplements; Docosahexaenoic Acids; Humans; Lutein; Macular Degeneration; Microalgae; Models, Animal; Quail; Retina; Zeaxanthins | 2015 |
Dietary sources of lutein in adults suffering eye disease (AMD/cataracts).
Topics: Aged; Aged, 80 and over; Carotenoids; Dietary Supplements; Female; Food Preferences; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Nutritional Physiological Phenomena; Poland; Sex Distribution; Vitamin A; Vitamin E; Vitamins; Zinc | 2015 |
Lifestyles and Cognitive Health: What Older Individuals Can Do to Optimize Cognitive Outcomes.
Topics: Cognition; Cognitive Dysfunction; Dementia; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Executive Function; Exercise Therapy; Female; Health Promotion; Humans; Lutein; Macular Degeneration; Male; Sedentary Behavior; Vitamins; Zeaxanthins | 2015 |
Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration.
Topics: Aged; Alleles; Complement Factor H; Diet; Feeding Behavior; Female; Genotyping Techniques; Health Status Indicators; Humans; Life Style; Lutein; Macular Degeneration; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Prevalence; Proteins; Risk Factors; Women's Health; Zeaxanthins | 2015 |
Dietary Components Affect the Plasma and Tissue Levels of Lutein in Aged Rats with Lutein Deficiency--A Repeated Gavage and Dietary Study.
Topics: Animals; Antioxidants; beta Carotene; Biological Availability; Diet; Dietary Fiber; Eye; Intestinal Absorption; Liver; Lutein; Macular Degeneration; Male; Micelles; Phosphatidylcholines; Rats, Wistar; Soybean Oil; Tissue Distribution; Vegetables; Zeaxanthins | 2015 |
Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.
Topics: Adult; Aged; Antioxidants; Carotenoids; Feeding Behavior; Female; Follow-Up Studies; Health Personnel; Humans; Incidence; Lutein; Macular Degeneration; Male; Middle Aged; Nutrition Surveys; Prospective Studies; Risk Factors; Surveys and Questionnaires; United States; Zeaxanthins | 2015 |
Diet rich in carotenoids is linked to reduced risk of advanced age related macular degeneration.
Topics: Antioxidants; Carotenoids; Female; Humans; Lutein; Macular Degeneration; Male; Zeaxanthins | 2015 |
REPRODUCIBILITY OF MACULAR PIGMENT OPTICAL DENSITY MEASUREMENT BY TWO-WAVELENGTH AUTOFLUORESCENCE IN A CLINICAL SETTING.
Topics: Adult; Aged; Aged, 80 and over; Densitometry; Diabetic Retinopathy; Female; Humans; Lutein; Macular Degeneration; Macular Edema; Macular Pigment; Male; Middle Aged; Optical Imaging; Reproducibility of Results; Zeaxanthins | 2016 |
Risk Factors and Age-Related Macular Degeneration in a Mediterranean-Basin Population: The PAMDI (Prevalence of Age-Related Macular Degeneration in Italy) Study--Report 2.
Topics: Aged; Aged, 80 and over; Alcohol Drinking; Cross-Sectional Studies; Diet; Feeding Behavior; Female; Humans; Italy; Lutein; Macular Degeneration; Male; Middle Aged; Prevalence; Retinal Drusen; Risk Factors; Rural Population; Smoking; Urban Population | 2016 |
Oral Nutrient Supplementation and Cognitive Function.
Topics: Cognition; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Vitamins; Zeaxanthins | 2016 |
Oral Nutrient Supplementation and Cognitive Function.
Topics: Cognition; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Vitamins; Zeaxanthins | 2016 |
Oral Nutrient Supplementation and Cognitive Function--Reply.
Topics: Cognition; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Vitamins; Zeaxanthins | 2016 |
[Supplements for cognitive function unsuitable].
Topics: Cognition; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Vitamins; Zeaxanthins | 2015 |
Ask the doctor. I've heard that age-related macular degeneration is a common cause of blindness. Do copper, zinc, or lutein help prevent it?
Topics: Blindness; Copper; Humans; Lutein; Macular Degeneration; Zinc | 2013 |
Perspective: A Critical Look at the Ancillary Age-Related Eye Disease Study 2: Nutrition and Cognitive Function Results in Older Individuals with Age-Related Macular Degeneration.
Topics: Aged; Aging; Clinical Trials as Topic; Cognition Disorders; Fatty Acids; Female; Humans; Lutein; Macular Degeneration; Male; Research Design; Zeaxanthins | 2016 |
Comment on "Perspective: A Critical Look at the Ancillary Age-Related Eye Disease Study 2: Nutrition and Cognitive Function Results in Older Individuals with Age-Related Macular Degeneration".
Topics: Cognition; Humans; Lutein; Macular Degeneration; Nutritional Status | 2016 |
Lutein acts via multiple antioxidant pathways in the photo-stressed retina.
Topics: Animals; Antioxidants; Cell Line; Choroid; Humans; Light; Lutein; Macrophages; Macular Degeneration; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Reactive Oxygen Species; Retina; Retinal Pigment Epithelium; RNA, Messenger; Superoxide Dismutase; Superoxide Dismutase-1; Tight Junctions; Up-Regulation | 2016 |
Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation.
Topics: Aged; Aged, 80 and over; Dietary Supplements; Female; Follow-Up Studies; Humans; Lutein; Macula Lutea; Macular Degeneration; Macular Pigment; Male; Middle Aged; Phenotype; Pilot Projects; Prospective Studies; Time Factors; Visual Acuity; Zeaxanthins | 2017 |
Pretreatment of RPE Cells with Lutein Can Mitigate Bevacizumab-Induced Increases in Angiogenin and bFGF.
Topics: Angiogenesis Inhibitors; Bevacizumab; Cell Survival; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Humans; Lutein; Macular Degeneration; Middle Aged; Retinal Pigment Epithelium; Ribonuclease, Pancreatic; Signal Transduction | 2017 |
Non-Dietary Correlates and Determinants of Plasma Lutein and Zeaxanthin Concentrations in the Irish Population.
Topics: Aged; Aging; Body Mass Index; Carotenoids; Cholesterol; Cohort Studies; Cross-Sectional Studies; Exercise; Eye; Female; Health Status; Humans; Ireland; Lipoproteins, HDL; Lipoproteins, LDL; Longitudinal Studies; Lutein; Macular Degeneration; Macular Pigment; Male; Middle Aged; Photometry; Prospective Studies; Residence Characteristics; Surveys and Questionnaires; Zeaxanthins | 2017 |
Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration.
Topics: Aging; Energy Intake; Feeding Behavior; Female; Follow-Up Studies; Humans; Incidence; Lutein; Macular Degeneration; Male; Middle Aged; Risk; Risk Assessment; Surveys and Questionnaires; Xanthophylls; Zeaxanthins | 2008 |
Lutein and zeaxanthin for macular degeneration.
Topics: Aged; Drug-Related Side Effects and Adverse Reactions; Humans; Lutein; Macular Degeneration; Outcome Assessment, Health Care; Xanthophylls; Zeaxanthins | 2008 |
[The assessment and characteristic of dietary supplements with lutein and zeaxanthin on the Polish pharmaceutical market].
Topics: Dietary Supplements; Drug Industry; Humans; Lutein; Macular Degeneration; Micronutrients; Nonprescription Drugs; Plant Extracts; Poland; Xanthophylls; Zeaxanthins | 2008 |
Lutein/zeaxanthin.
Topics: Atrophy; Choroidal Neovascularization; Diet; Humans; Lutein; Macular Degeneration; Pigment Epithelium of Eye; Retinal Drusen; Vitamins; Xanthophylls; Zeaxanthins | 2008 |
Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Cross-Sectional Studies; Diet; Diet Surveys; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Energy Intake; Fatty Acids, Unsaturated; Feeding Behavior; Female; Glycemic Index; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Retinal Drusen; Risk Assessment; Vitamin E; Xanthophylls; Zeaxanthins; Zinc | 2009 |
A descriptive study of lutein and zeaxanthin in optometric practice.
Topics: Adult; Aged; Antioxidants; Cataract; Female; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Optometry; Practice Patterns, Physicians'; Surveys and Questionnaires; Wisconsin; Xanthophylls; Zeaxanthins | 2009 |
rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration.
Topics: Aged; Case-Control Studies; Female; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Lipid Metabolism; Lipids; Lutein; Macular Degeneration; Male; Middle Aged; Polymorphism, Genetic; Scavenger Receptors, Class B | 2009 |
Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health Initiative.
Topics: Aged; Dietary Fats; Fatty Acids; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Feeding Behavior; Female; Humans; Lutein; Macular Degeneration; Middle Aged; Prevalence; Risk Factors; Surveys and Questionnaires; United States; Women's Health | 2009 |
Patients with Sjögren-Larsson syndrome lack macular pigment.
Topics: Adolescent; Adult; Child; Child, Preschool; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Ophthalmoscopy; Sjogren-Larsson Syndrome; Tomography, Optical Coherence; Visual Acuity; Xanthophylls; Young Adult; Zeaxanthins | 2010 |
[Impact of eating habits on macular pathology assessed by macular pigment optical density measure].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Brassica; Capsicum; Dietary Supplements; Feeding Behavior; Female; Fruit; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Pilot Projects; Retinal Drusen; Retinal Neovascularization; Retinal Pigment Epithelium; Risk Factors; Spinacia oleracea; Vegetables; Xanthophylls; Young Adult; Zea mays; Zeaxanthins | 2010 |
Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Dietary Supplements; Drug Combinations; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Photometry; Pilot Projects; Retinal Pigments; Visual Acuity; Xanthophylls; Zeaxanthins | 2010 |
Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Aging; Female; Humans; Ireland; Longitudinal Studies; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Photometry; Pilot Projects; Retinal Pigments; Sex Distribution; Xanthophylls; Young Adult; Zeaxanthins | 2010 |
A central dip in the macular pigment spatial profile is associated with age and smoking.
Topics: Adolescent; Adult; Aged; Aging; Alcohol Drinking; Chromatography, High Pressure Liquid; Eye Color; Feeding Behavior; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Photometry; Retinal Pigments; Risk Factors; Smoking; Surveys and Questionnaires; Xanthophylls; Young Adult; Zeaxanthins | 2010 |
Carotenoid content and in vitro bioaccessibility of lutein in some leafy vegetables popular in Sri Lanka.
Topics: Araceae; beta Carotene; Carotenoids; Chromatography, High Pressure Liquid; Cooking; Crops, Agricultural; Diet; Ipomoea batatas; Lutein; Macular Degeneration; Nutritive Value; Plant Leaves; Sri Lanka; Vegetables; Vitamin A Deficiency | 2010 |
Intake of lutein and zeaxanthin differ with age, sex, and ethnicity.
Topics: Adolescent; Adult; Age Distribution; Aged; Child; Child, Preschool; Chromatography, High Pressure Liquid; Diet; Female; Food Analysis; Humans; Infant; Lutein; Macular Degeneration; Male; Middle Aged; Nutrition Assessment; Nutrition Surveys; Nutritional Physiological Phenomena; Nutritional Requirements; Sex Distribution; Xanthophylls; Young Adult; Zeaxanthins | 2010 |
Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans.
Topics: beta-Carotene 15,15'-Monooxygenase; Carrier Proteins; CD36 Antigens; Dietary Supplements; Genetic Variation; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Oxygenases; Polymorphism, Single Nucleotide | 2011 |
Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Body Mass Index; Demography; Female; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Life Style; Lipase; Lutein; Macular Degeneration; Male; Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Smoking | 2010 |
Healthy lifestyles related to subsequent prevalence of age-related macular degeneration.
Topics: Aged; C-Reactive Protein; Chromatography, High Pressure Liquid; Diet; Exercise; Feeding Behavior; Female; Health Behavior; Humans; Life Style; Lutein; Macular Degeneration; Middle Aged; Prevalence; Risk Factors; Surveys and Questionnaires; Tocopherols; United States; Xanthophylls; Zeaxanthins | 2011 |
Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Dietary Supplements; Disease Models, Animal; Fatty Acids, Omega-3; Fovea Centralis; Light; Lutein; Macaca mulatta; Macular Degeneration; Oxidative Stress; Radiation-Protective Agents; Xanthophylls; Zeaxanthins | 2011 |
Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Muenster Aging and Retina Study (MARS).
Topics: Aged; Aging; Antioxidants; Body Mass Index; Densitometry; Dietary Supplements; Female; Fluorescein Angiography; Humans; Lutein; Macular Degeneration; Male; Prospective Studies; Retinal Pigments; Smoking; Xanthophylls; Zeaxanthins | 2011 |
Cataract is a self-defence reaction to protect the retina from oxidative damage.
Topics: Aged; Antioxidants; Carotenoids; Cataract; Coagulants; Humans; Lens, Crystalline; Light; Lutein; Macular Degeneration; Middle Aged; Models, Biological; Oxidative Stress; Retina; Xanthophylls; Zeaxanthins | 2011 |
Macular pigment distribution in Stargardt macular disease.
Topics: Adolescent; Adult; Anthropometry; ATP-Binding Cassette Transporters; Case-Control Studies; Densitometry; Female; Fluorescein Angiography; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Ophthalmoscopy; Prognosis; Prospective Studies; Scanning Laser Polarimetry; Stargardt Disease; Visual Acuity; Xanthophylls; Young Adult; Zeaxanthins | 2011 |
[Changes of macular pigment and drusen morphology in patients with lutein supplementation].
Topics: Aged, 80 and over; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Optic Disk Drusen; Treatment Outcome; Xanthophylls; Zeaxanthins | 2012 |
Focus on molecules: lutein.
Topics: Humans; Lutein; Macular Degeneration; Retina | 2012 |
The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype.
Topics: Adult; Aged; Complement C2; Complement C3; Complement Factor B; Complement Factor H; Cross-Sectional Studies; Densitometry; Diet; Feeding Behavior; Female; Genotype; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Multiplex Polymerase Chain Reaction; Photometry; Polymorphism, Single Nucleotide; Proteins; Retinal Pigments; Xanthophylls; Young Adult; Zeaxanthins | 2011 |
[Influence of the lutein-rich products consumption on its supply in diet of individuals with age-related macular degeneration (AMD)].
Topics: Aged; Aged, 80 and over; Antioxidants; Choice Behavior; Diet; Diet Records; Female; Food Preferences; Fruit; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Poland; Vegetables | 2011 |
The ringlike structure of macular pigment in age-related maculopathy: results from the Muenster Aging and Retina Study (MARS).
Topics: Aged; Aging; Cross-Sectional Studies; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Lipofuscin; Lutein; Macular Degeneration; Male; Retina; Retinal Pigments; Xanthophylls; Zeaxanthins | 2011 |
Sjögren-larsson syndrome.
Topics: Female; Humans; Lutein; Macular Degeneration; Male; Sjogren-Larsson Syndrome; Xanthophylls | 2011 |
Lutein or zeaxanthin supplementation suppresses inflammatory responses in retinal pigment epithelial cells and macrophages.
Topics: Animals; Cells, Cultured; Dietary Supplements; Interleukin-6; Interleukin-8; Lipopolysaccharides; Lutein; Macrophages; Macular Degeneration; Mice; Mice, Inbred C57BL; Oxidative Stress; Retinal Pigment Epithelium; Tumor Necrosis Factor-alpha; Xanthophylls; Zeaxanthins | 2012 |
Use of micronutrient supplement for preventing advanced age-related macular degeneration in Japan.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Attitude of Health Personnel; beta Carotene; Dietary Supplements; Female; Health Surveys; Humans; Japan; Lutein; Macular Degeneration; Male; Micronutrients; Middle Aged; Nutritional Support; Ophthalmology; Surveys and Questionnaires; Vitamin E; Zinc | 2012 |
Structural aspects of the antioxidant activity of lutein in a model of photoreceptor membranes.
Topics: Animals; Antioxidants; Humans; Lipid Peroxidation; Liposomes; Lutein; Macular Degeneration; Singlet Oxygen; Xanthophylls | 2012 |
The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.
Topics: Adolescent; Adult; Antioxidants; Dietary Supplements; Female; Humans; Lutein; Macular Degeneration; Middle Aged; Prospective Studies; Retinal Pigments; Xanthophylls; Young Adult; Zeaxanthins | 2012 |
Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells.
Topics: Cells, Cultured; Chemokine CCL2; Complement Factor H; Culture Media; Dietary Supplements; Down-Regulation; Gene Expression; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Lutein; Macular Degeneration; Oxidation-Reduction; Oxidative Stress; Photochemical Processes; Proteasome Endopeptidase Complex; Radiation-Protective Agents; Retinal Pigment Epithelium; Ultraviolet Rays; Xanthophylls; Zeaxanthins | 2012 |
Profiles of macular pigment optical density and their changes following supplemental lutein and zeaxannthin.
Topics: Dietary Supplements; Female; Humans; Lutein; Macular Degeneration; Male; Retina; Retinal Pigments; Xanthophylls | 2012 |
Comparison of macular pigment in patients with age-related macular degeneration and healthy control subjects - a study using spectral fundus reflectance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Densitometry; Diagnostic Techniques, Ophthalmological; Female; Heart Rate; Humans; Intraocular Pressure; Lutein; Macular Degeneration; Male; Middle Aged; Retina; Retinal Pigments; Xanthophylls; Young Adult; Zeaxanthins | 2012 |
Neovascular age-related macular degeneration and its relationship to antioxidant intake.
Topics: Aged; Antioxidants; beta Carotene; Case-Control Studies; Diet; Feeding Behavior; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Odds Ratio; Prevalence; Risk Factors; Xanthophylls; Zeaxanthins | 2002 |
Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients.
Topics: Aged; Aged, 80 and over; Aging; beta Carotene; Dietary Supplements; Dose-Response Relationship, Drug; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Reference Values; Spectrum Analysis, Raman; Xanthophylls; Zeaxanthins | 2002 |
Seeing yellow.
Topics: Cataract; Humans; Lutein; Macular Degeneration | 2002 |
An efficient conversion of (3R,3'R,6'R)-lutein to (3R,3'S,6'R)-lutein (3'-epilutein) and (3R,3'R)-zeaxanthin.
Topics: beta Carotene; Biotransformation; Carotenoids; Chromatography, High Pressure Liquid; Dietary Supplements; Flowers; Humans; Lipase; Lutein; Macular Degeneration; Mass Spectrometry; Milk, Human; Molecular Structure; Plants, Medicinal; Plasma; Pseudomonas fluorescens; Spectrophotometry, Ultraviolet; Stereoisomerism; Tagetes; Xanthophylls; Zeaxanthins | 2003 |
Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans.
Topics: Adult; beta Carotene; Dietary Supplements; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Xanthophylls; Zeaxanthins | 2003 |
Short-term supplementation with lutein affects biomarkers of lutein status similarly in young and elderly subjects.
Topics: Adipose Tissue; Adult; Aged; Aging; Biomarkers; Chromatography, High Pressure Liquid; Dietary Supplements; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Mouth Mucosa; Retinal Pigments | 2003 |
Lutein and zeaxanthin status and risk of age-related macular degeneration.
Topics: Aged; beta Carotene; Female; Humans; Lutein; Macular Degeneration; Male; Odds Ratio; Risk Factors; Xanthophylls; Zeaxanthins | 2003 |
Resonance Raman measurement of macular carotenoids in retinal, choroidal, and macular dystrophies.
Topics: Adult; beta Carotene; Choroideremia; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Retinal Pigments; Retinitis Pigmentosa; Spectrum Analysis, Raman; Xanthophylls; Zeaxanthins | 2003 |
Are lutein and zeaxanthin conditionally essential nutrients for eye health?
Topics: Aging; Antioxidants; beta Carotene; Carotenoids; Dietary Supplements; Humans; Lutein; Macular Degeneration; Models, Theoretical; Ocular Physiological Phenomena; Oxidative Stress; Retina; Xanthophylls; Zeaxanthins | 2003 |
Macular pigment: quantitative analysis on autofluorescence images.
Topics: Adult; Aged; Aged, 80 and over; beta Carotene; Densitometry; Diagnostic Imaging; Female; Fluorescence; Humans; Lasers; Lutein; Macular Degeneration; Male; Middle Aged; Ophthalmoscopy; Retinal Pigments; Xanthophylls; Zeaxanthins | 2003 |
Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Dietary Supplements; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Photometry; Pilot Projects | 2004 |
Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; beta Carotene; Cataract; Cross-Sectional Studies; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Phacoemulsification; Photometry; Prospective Studies; Retinal Pigments; Xanthophylls; Zeaxanthins | 2004 |
Age-related macular degeneration and its possible prevention.
Topics: Age Factors; Aged; beta Carotene; Dietary Supplements; Humans; Lutein; Macular Degeneration; Treatment Outcome; Xanthophylls; Zeaxanthins | 2005 |
Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS).
Topics: Aged; Aged, 80 and over; Aging; beta Carotene; Biomarkers; Dietary Supplements; Disease Progression; Female; Follow-Up Studies; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Stereoisomerism; Xanthophylls; Zeaxanthins | 2005 |
Nutritional manipulation of primate retinas. IV. Effects of n--3 fatty acids, lutein, and zeaxanthin on S-cones and rods in the foveal region.
Topics: alpha-Linolenic Acid; Animal Nutritional Physiological Phenomena; Animals; beta Carotene; Cell Count; Dietary Supplements; Fatty Acids, Omega-3; Fovea Centralis; Immunohistochemistry; Lutein; Macaca mulatta; Macular Degeneration; Microscopy, Fluorescence; Retinal Cone Photoreceptor Cells; Rod Cell Outer Segment; Xanthophylls; Zeaxanthins | 2005 |
Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients.
Topics: Adult; Age Factors; Aged; Antioxidants; beta Carotene; Carotenoids; Copper; Diet; France; Humans; Lipoproteins; Lutein; Lycopene; Macular Degeneration; Male; Middle Aged; Tocopherols; Xanthophylls; Zeaxanthins | 2005 |
Lutein and zeaxanthin. Monograph.
Topics: beta Carotene; Cardiovascular Diseases; Cataract; Humans; Lung Neoplasms; Lutein; Macular Degeneration; Radiodermatitis; Retinitis Pigmentosa; Xanthophylls; Zeaxanthins | 2005 |
Oxidative stress in ocular disease: does lutein play a protective role?
Topics: Cataract; Diet; Epidemiologic Studies; Humans; Lutein; Macular Degeneration; Oxidative Stress; Retina; Risk Factors | 2005 |
Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project.
Topics: Aged; beta Carotene; Diet; Female; Follow-Up Studies; Humans; Linoleic Acid; Lutein; Macular Degeneration; Male; Middle Aged; Xanthophylls; Zeaxanthins | 2006 |
Doubts about lutein.
Topics: Cataract; Epidemiologic Studies; Humans; Lutein; Macular Degeneration | 2006 |
I recently read that zeaxanthin may help prevent cataracts. Does it also help treat macular degeneration? And is it better than lutein for macular degeneration?
Topics: beta Carotene; Cataract; Humans; Lutein; Macular Degeneration; Xanthophylls; Zeaxanthins | 2006 |
Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods.
Topics: Adult; Aged; Aged, 80 and over; Densitometry; Diagnostic Techniques, Ophthalmological; Female; Fluorescence; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Reproducibility of Results; Retinal Pigments; Xanthophylls; Zeaxanthins | 2006 |
Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study.
Topics: beta Carotene; Cataract; Chromatography, High Pressure Liquid; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Risk Factors; Xanthophylls; Zeaxanthins | 2006 |
Lutein and zeaxanthin dietary intake and age related macular degeneration.
Topics: Cohort Studies; Diet; Humans; Linoleic Acid; Lutein; Macular Degeneration; Middle Aged; Photography; Xanthophylls; Zeaxanthins | 2006 |
Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative.
Topics: Aged; Aging; Diet; Diet Records; Eating; Female; Humans; Lutein; Macular Degeneration; Middle Aged; Odds Ratio; Prevalence; United States; Women's Health; Xanthophylls; Zeaxanthins | 2006 |
Dietary lutein and zeaxanthin: authors' response.
Topics: Diet; Humans; Lutein; Macular Degeneration; Research Design; Xanthophylls; Zeaxanthins | 2006 |
Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative.
Topics: Aged; Aged, 80 and over; Aging; Cohort Studies; Diet; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Middle Aged; Obesity; Prospective Studies; Retina; United States; Women's Health; Xanthophylls; Zeaxanthins | 2006 |
Influence of macular pigment and melanin on incident early AMD in a white population.
Topics: Antioxidants; Female; Humans; Incidence; Longitudinal Studies; Lutein; Macula Lutea; Macular Degeneration; Male; Melanins; Middle Aged; Netherlands; Proportional Hazards Models; Retinal Pigments; Xanthophylls; Zeaxanthins | 2007 |
Solubility, uptake and biocompatibility of lutein and zeaxanthin delivered to cultured human retinal pigment epithelial cells in tween40 micelles.
Topics: Cataract; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Epithelial Cells; Gene Expression Regulation; Humans; L-Lactate Dehydrogenase; Lutein; Macular Degeneration; Micelles; Polysorbates; Retina; Solubility; Xanthophylls; Zeaxanthins | 2007 |
The relationships between macular pigment optical density and its constituent carotenoids in diet and serum.
Topics: Adult; Chromatography, High Pressure Liquid; Diet; Energy Intake; Feeding Behavior; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Photometry; Retinal Pigments; Risk Factors; Smoking; Surveys and Questionnaires; Xanthophylls; Zeaxanthins | 2007 |
Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
Topics: Aged; Aged, 80 and over; Antioxidants; Dietary Supplements; Female; Humans; Lipoproteins, HDL; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Xanthophylls; Zeaxanthins | 2007 |
Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Biological Transport; Body Weight; Carotenoids; Diet; Female; Humans; Lipids; Lipoproteins; Lutein; Macular Degeneration; Male; Xanthophylls; Zeaxanthins | 2007 |
Macular pigment in the human retina: histological evaluation of localization and distribution.
Topics: Adult; Aged; Aged, 80 and over; Humans; Lutein; Macula Lutea; Macular Degeneration; Middle Aged; Retinal Pigments; Xanthophylls; Zeaxanthins | 2008 |
Investigation of the effect of simulated lens yellowing, transparency loss and refractive error on in vivo resonance Raman spectroscopy.
Topics: Adult; Aging; Humans; Lens, Crystalline; Lutein; Macular Degeneration; Refraction, Ocular; Spectrum Analysis, Raman; Xanthophylls; Zeaxanthins | 2007 |
[Macular pigment and age-related macular degeneration. Clinical implications].
Topics: Aged; Aging; Antioxidants; beta Carotene; Dietary Supplements; Humans; Lutein; Macula Lutea; Macular Degeneration; Middle Aged; Xanthophylls; Zeaxanthins | 2006 |
Macular pigment optical density at four retinal loci during 120 days of lutein supplementation.
Topics: Adult; Dietary Supplements; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Photometry; Visual Acuity; Xanthophylls; Zeaxanthins | 2007 |
Measurement of macular pigment optical density using two different heterochromatic flicker photometers.
Topics: Adult; Aged; Female; Flicker Fusion; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Photometry; Retinal Pigments; Xanthophylls; Zeaxanthins | 2007 |
The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Carotenoids; Case-Control Studies; Choroidal Neovascularization; Diet; Eating; Energy Intake; Feeding Behavior; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Nutrition Surveys; Regression Analysis; Surveys and Questionnaires; Vitamin A; Vitamin E; Xanthophylls; Zeaxanthins | 2007 |
Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative.
Topics: Aged; Aged, 80 and over; Bias; Cross-Sectional Studies; Diet; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Middle Aged; Odds Ratio; Photometry; Postmenopause; Retinal Pigments; Risk Factors; Surveys and Questionnaires; Women's Health; Xanthophylls; Zeaxanthins | 2008 |
Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population.
Topics: Adult; Aged; Aged, 80 and over; Aging; Case-Control Studies; Female; Humans; Japan; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Spectrum Analysis, Raman; Xanthophylls; Zeaxanthins | 2008 |
AMD study: a feast for the eyes.
Topics: Aged; Aged, 80 and over; Antioxidants; beta Carotene; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Middle Aged; Xanthophylls; Zeaxanthins; Zinc Compounds | 2007 |
Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.
Topics: Aged; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Placebos; Reference Values; Time Factors; Visual Acuity; Xanthophylls; Zeaxanthins | 2008 |
Serum antioxidants and age-related macular degeneration in a population-based case-control study.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; beta Carotene; Carotenoids; Case-Control Studies; Cohort Studies; Female; Fundus Oculi; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Vitamin E; Wisconsin; Xanthophylls; Zeaxanthins | 1995 |
The macular pigment: a possible role in protection from age-related macular degeneration.
Topics: Adult; Aging; Carotenoids; Humans; Lutein; Macular Degeneration; Male; Retinal Pigments | 1997 |
Dietary modification of human macular pigment density.
Topics: Adult; Aged; beta Carotene; Chromatography, High Pressure Liquid; Diet; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Retina; Retinal Pigments; Spinacia oleracea; Xanthophylls; Zea mays; Zeaxanthins | 1997 |
Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes.
Topics: beta Carotene; Carotenoids; Chromatography, High Pressure Liquid; Color; Egg Yolk; Fruit; Humans; Lutein; Macular Degeneration; Vegetables; Xanthophylls; Zeaxanthins | 1998 |
[Age-related maculopathy. Comparative studies of patients, their children and healthy controls].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Fluorescence; Fundus Oculi; Genetic Predisposition to Disease; Humans; Lutein; Macula Lutea; Macular Degeneration; Middle Aged; Oxygen; Prospective Studies; Retinal Diseases; Spectrum Analysis | 2000 |
Lutein and zeaxanthin in the eyes, serum and diet of human subjects.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta Carotene; Chromatography, High Pressure Liquid; Diet; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Photometry; Xanthophylls; Zeaxanthins | 2000 |
Macular pigment in donor eyes with and without AMD: a case-control study.
Topics: Aged; Aged, 80 and over; beta Carotene; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Retina; Retinal Pigments; Risk Factors; Tissue Donors; Xanthophylls; Zeaxanthins | 2001 |
Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population.
Topics: Adult; Aged; Aged, 80 and over; Aging; beta Carotene; Diet; Energy Intake; Europe; Eye Color; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Retinal Pigments; Risk Factors; Xanthophylls; Zeaxanthins | 2001 |
Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; beta Carotene; Diet; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Nutrition Surveys; Odds Ratio; Risk Factors; United States; Xanthophylls; Zeaxanthins | 2001 |
Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants.
Topics: alpha-Tocopherol; Animals; Animals, Newborn; Antioxidants; beta Carotene; Carotenoids; Cattle; Epithelial Cells; Free Radicals; Humans; In Vitro Techniques; Lipofuscin; Lutein; Lycopene; Macular Degeneration; Pigment Epithelium of Eye; Rabbits; Xanthophylls; Zeaxanthins | 2001 |
Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population.
Topics: Adult; beta Carotene; Carotenoids; Chromatography, High Pressure Liquid; Diet; Female; Humans; Lutein; Macular Degeneration; Male; Retinal Pigments; Smoking; Surveys and Questionnaires; Xanthophylls; Zeaxanthins | 2001 |
[Objective determination of optical density of xanthophyll after supplementation of lutein].
Topics: Adult; Female; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Microscopy, Confocal; Middle Aged; Ophthalmoscopy; Spectrum Analysis; Xanthophylls | 2002 |